<html lang="en">
<head>
<title>Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1</title>
<base href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC316375/">
</head>
<body class="pmc article">
    <div class="pmc-grid wrap grid clearfix">
      <div class="col twelve_col page nomargin shadow">

        
        <div class="sysmessages">
          <noscript>
<p class="nojs">
<strong>Warning:</strong>
The NCBI web site requires JavaScript to function. 
<a href="http://www.ncbi.nlm.nih.gov/corehtml/query/static/unsupported-browser.html#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
</p>
</noscript>
        </div>
        
        
        
        <div>
    <div class="universal_header" id="universal_header">
<ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent">
<li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/guide/" title="NCBI Home" id="ncbihome" accesskey="1"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/3467497/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li>
<li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset">
<a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor" href="/guide/all/">Resources</a><ul id="resources-submenu">
<li><a href="/guide/all/">All Resources</a></li>
<li>
<a href="#chemicals-bioassays">Chemicals &amp; Bioassays</a><ul class="actual-resources-submenu chemicals-bioassays">
<li><a href="/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. ">BioSystems</a></li>
<li><a href="/pcassay" title=" Contributed bioactivity data for PubChem Substances ">PubChem BioAssay</a></li>
<li><a href="/pccompound" title=" Unique, standardized chemical structures ">PubChem Compound</a></li>
<li><a href="http://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure ">PubChem Structure Search</a></li>
<li><a href="/pcsubstance" title=" Provides information on the biological activities of small molecules. ">PubChem Substance</a></li>
<li><a href="/guide/chemicals-bioassays/">All Chemicals &amp; Bioassays Resources...</a></li>
</ul>
</li>
<li>
<a href="#dna-rna">DNA &amp; RNA</a><ul class="actual-resources-submenu dna-rna">
<li><a href="http://blast.ncbi.nlm.nih.gov" title=" Tool for finding local regions of sequence similarity ">BLAST (Basic Local Alignment Search Tool)</a></li>
<li><a href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer ">BLAST (Stand-alone)</a></li>
<li><a href="/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI's Entrez system ">E-Utilities</a></li>
<li><a href="/genbank/" title=" DNA and RNA sequences submitted to NCBI ">GenBank</a></li>
<li><a href="/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences ">GenBank: BankIt</a></li>
<li><a href="/projects/Sequin" title=" Software tool for complex submissions of nucleotide sequences ">GenBank: Sequin</a></li>
<li><a href="/genbank/tbl2asn2.html" title=" Command-line program for submitting sequence data ">GenBank: tbl2asn</a></li>
<li><a href="/projects/gbench/" title=" Stand-alone application for analyzing sequence data ">Genome Workbench</a></li>
<li><a href="/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project ">Influenza Virus</a></li>
<li><a href="/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq ">Nucleotide Database</a></li>
<li><a href="/popset" title=" Sets of nucleotide sequences representing a population ">PopSet</a></li>
<li><a href="/tools/primer-blast" title=" Designs PCR primers and analyzes them for target specificity using BLAST. ">Primer-BLAST</a></li>
<li><a href="/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA ">ProSplign</a></li>
<li><a href="/RefSeq/" title=" Curated nucleotide and protein sequences produced by NCBI ">Reference Sequence (RefSeq)</a></li>
<li><a href="/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes ">RefSeqGene</a></li>
<li><a href="/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies ">Sequence Read Archive (SRA)</a></li>
<li><a href="/sutils/splign" title=" Tool for aligning transcripts to genomic DNA ">Splign</a></li>
<li><a href="/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. ">Trace Archive</a></li>
<li><a href="/unigene" title=" Gene-centered clusters of transcripts and ESTs ">UniGene</a></li>
<li><a href="/unists" title=" Database of Sequence Tagged Sites ">UniSTS</a></li>
<li><a href="/guide/dna-rna/">All DNA &amp; RNA Resources...</a></li>
</ul>
</li>
<li>
<a href="#data-software">Data &amp; Software</a><ul class="actual-resources-submenu data-software">
<li><a href="http://blast.ncbi.nlm.nih.gov" title=" Tool for finding local regions of sequence similarity ">BLAST (Basic Local Alignment Search Tool)</a></li>
<li><a href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer ">BLAST (Stand-alone)</a></li>
<li><a href="/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments ">Cn3D</a></li>
<li><a href="/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence ">Conserved Domain Search Service (CD Search)</a></li>
<li><a href="/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI's Entrez system ">E-Utilities</a></li>
<li><a href="/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences ">GenBank: BankIt</a></li>
<li><a href="/projects/Sequin" title=" Software tool for complex submissions of nucleotide sequences ">GenBank: Sequin</a></li>
<li><a href="/genbank/tbl2asn2.html" title=" Command-line program for submitting sequence data ">GenBank: tbl2asn</a></li>
<li><a href="/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome ">Genome ProtMap</a></li>
<li><a href="/projects/gbench/" title=" Stand-alone application for analyzing sequence data ">Genome Workbench</a></li>
<li><a href="/tools/primer-blast" title=" Designs PCR primers and analyzes them for target specificity using BLAST. ">Primer-BLAST</a></li>
<li><a href="/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA ">ProSplign</a></li>
<li><a href="http://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure ">PubChem Structure Search</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/projects/SNP" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. ">SNP Submission Tool</a></li>
<li><a href="/sutils/splign" title=" Tool for aligning transcripts to genomic DNA ">Splign</a></li>
<li><a href="/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments ">Vector Alignment Search Tool (VAST)</a></li>
<li><a href="/guide/data-software/">All Data &amp; Software Resources...</a></li>
</ul>
</li>
<li>
<a href="#domains-structures">Domains &amp; Structures</a><ul class="actual-resources-submenu domains-structures">
<li><a href="/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. ">BioSystems</a></li>
<li><a href="/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments ">Cn3D</a></li>
<li><a href="/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments ">Conserved Domain Database (CDD)</a></li>
<li><a href="/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence ">Conserved Domain Search Service (CD Search)</a></li>
<li><a href="/sites/entrez?db=structure" title=" Database of 3D macromolecular structures derived from PDB ">Structure (Molecular Modeling Database)</a></li>
<li><a href="/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments ">Vector Alignment Search Tool (VAST)</a></li>
<li><a href="/guide/domains-structures/">All Domains &amp; Structures Resources...</a></li>
</ul>
</li>
<li>
<a href="#genes-expression">Genes &amp; Expression</a><ul class="actual-resources-submenu genes-expression">
<li><a href="/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. ">BioSystems</a></li>
<li><a href="/gap" title=" Genotype/Phenotype association studies ">Database of Genotypes and Phenotypes (dbGaP)</a></li>
<li><a href="/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI's Entrez system ">E-Utilities</a></li>
<li><a href="/gene" title=" Database of gene loci and associated transcripts and proteins ">Gene</a></li>
<li><a href="/geo/" title=" Gene Expression Omnibus (GEO) Database ">Gene Expression Omnibus (GEO) Database </a></li>
<li><a href="/gds" title=" Curated collections of gene expression data sets ">Gene Expression Omnibus (GEO) Datasets</a></li>
<li><a href="/geoprofiles/" title=" Database of gene expression Profiles for individual sequences ">Gene Expression Omnibus (GEO) Profiles</a></li>
<li><a href="/projects/gbench/" title=" Stand-alone application for analyzing sequence data ">Genome Workbench</a></li>
<li><a href="/homologene" title=" Sets of homologous eukaryotic genes ">HomoloGene</a></li>
<li><a href="/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data ">Map Viewer</a></li>
<li><a href="/omim" title=" Database of human genes and genetic disorders ">Online Mendelian Inheritance in Man (OMIM)</a></li>
<li><a href="/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes ">RefSeqGene</a></li>
<li><a href="/unigene" title=" Gene-centered clusters of transcripts and ESTs ">UniGene</a></li>
<li><a href="/guide/genes-expression/">All Genes &amp; Expression Resources...</a></li>
</ul>
</li>
<li>
<a href="#genetics-medicine">Genetics &amp; Medicine</a><ul class="actual-resources-submenu genetics-medicine">
<li><a href="/books" title=" Online biomedical books ">Bookshelf</a></li>
<li><a href="/gap" title=" Genotype/Phenotype association studies ">Database of Genotypes and Phenotypes (dbGaP)</a></li>
<li><a href="/gtr/" title=" Detailed information about genetic tests and labs ">Genetic Testing Registry</a></li>
<li><a href="/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project ">Influenza Virus</a></li>
<li><a href="/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data ">Map Viewer</a></li>
<li><a href="/omim" title=" Database of human genes and genetic disorders ">Online Mendelian Inheritance in Man (OMIM)</a></li>
<li><a href="/pubmed" title=" Biomedical literature abstracts ">PubMed</a></li>
<li><a href="/pmc/" title=" Free, full-text articles ">PubMed Central (PMC)</a></li>
<li><a href="/pubmed/clinical" title=" Directory of PubMed queries about clinical topics ">PubMed Clinical Queries</a></li>
<li><a href="/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes ">RefSeqGene</a></li>
<li><a href="/guide/genetics-medicine/">All Genetics &amp; Medicine Resources...</a></li>
</ul>
</li>
<li>
<a href="#genomes-maps">Genomes &amp; Maps</a><ul class="actual-resources-submenu genomes-maps">
<li><a href="/dbvar" title=" A database of genomic structural variation ">Database of Genomic Structural Variation (dbVar)</a></li>
<li><a href="/genbank/tbl2asn2.html" title=" Command-line program for submitting sequence data ">GenBank: tbl2asn</a></li>
<li><a href="/sites/genome" title=" Curated genomic DNA sequences ">Genome</a></li>
<li><a href="/genomeprj" title=" Central status pages for genome sequencing projects ">Genome Project</a></li>
<li><a href="/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome ">Genome ProtMap</a></li>
<li><a href="/projects/gbench/" title=" Stand-alone application for analyzing sequence data ">Genome Workbench</a></li>
<li><a href="/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project ">Influenza Virus</a></li>
<li><a href="/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data ">Map Viewer</a></li>
<li><a href="/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq ">Nucleotide Database</a></li>
<li><a href="/popset" title=" Sets of nucleotide sequences representing a population ">PopSet</a></li>
<li><a href="/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA ">ProSplign</a></li>
<li><a href="/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies ">Sequence Read Archive (SRA)</a></li>
<li><a href="/sutils/splign" title=" Tool for aligning transcripts to genomic DNA ">Splign</a></li>
<li><a href="/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. ">Trace Archive</a></li>
<li><a href="/unists" title=" Database of Sequence Tagged Sites ">UniSTS</a></li>
<li><a href="/guide/genomes-maps/">All Genomes &amp; Maps Resources...</a></li>
</ul>
</li>
<li>
<a href="#homology">Homology</a><ul class="actual-resources-submenu homology">
<li><a href="http://blast.ncbi.nlm.nih.gov" title=" Tool for finding local regions of sequence similarity ">BLAST (Basic Local Alignment Search Tool)</a></li>
<li><a href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer ">BLAST (Stand-alone)</a></li>
<li><a href="/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences ">BLAST Link (BLink)</a></li>
<li><a href="/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments ">Conserved Domain Database (CDD)</a></li>
<li><a href="/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence ">Conserved Domain Search Service (CD Search)</a></li>
<li><a href="/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome ">Genome ProtMap</a></li>
<li><a href="/homologene" title=" Sets of homologous eukaryotic genes ">HomoloGene</a></li>
<li><a href="/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles ">Protein Clusters</a></li>
<li><a href="/guide/homology/">All Homology Resources...</a></li>
</ul>
</li>
<li>
<a href="#literature">Literature</a><ul class="actual-resources-submenu literature">
<li><a href="/books" title=" Online biomedical books ">Bookshelf</a></li>
<li><a href="/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI's Entrez system ">E-Utilities</a></li>
<li><a href="/nlmcatalog/journals" title=" Information on journals cited by NCBI records ">Journals in NCBI Databases</a></li>
<li><a href="/mesh" title=" Controlled vocabulary for MEDLINE ">MeSH Database</a></li>
<li><a href="/books/NBK21101/" title=" Introductory articles about NCBI resources ">NCBI Handbook</a></li>
<li><a href="/books/NBK3831/" title=" Online, searchable help documentation ">NCBI Help Manual</a></li>
<li><a href="/books/NBK1969/" title=" NCBI's monthly newsletter ">NCBI News</a></li>
<li><a href="/pubmed" title=" Biomedical literature abstracts ">PubMed</a></li>
<li><a href="/pmc/" title=" Free, full-text articles ">PubMed Central (PMC)</a></li>
<li><a href="/pubmed/clinical" title=" Directory of PubMed queries about clinical topics ">PubMed Clinical Queries</a></li>
<li><a href="/guide/literature/">All Literature Resources...</a></li>
</ul>
</li>
<li>
<a href="#proteins">Proteins</a><ul class="actual-resources-submenu proteins">
<li><a href="/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. ">BioSystems</a></li>
<li><a href="http://blast.ncbi.nlm.nih.gov" title=" Tool for finding local regions of sequence similarity ">BLAST (Basic Local Alignment Search Tool)</a></li>
<li><a href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer ">BLAST (Stand-alone)</a></li>
<li><a href="/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences ">BLAST Link (BLink)</a></li>
<li><a href="/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments ">Conserved Domain Database (CDD)</a></li>
<li><a href="/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence ">Conserved Domain Search Service (CD Search)</a></li>
<li><a href="/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI's Entrez system ">E-Utilities</a></li>
<li><a href="/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA ">ProSplign</a></li>
<li><a href="/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles ">Protein Clusters</a></li>
<li><a href="/protein" title=" Protein sequence data ">Protein Database</a></li>
<li><a href="/RefSeq/" title=" Curated nucleotide and protein sequences produced by NCBI ">Reference Sequence (RefSeq)</a></li>
<li><a href="/guide/proteins/">All Proteins Resources...</a></li>
</ul>
</li>
<li>
<a href="#sequence-analysis">Sequence Analysis</a><ul class="actual-resources-submenu sequence-analysis">
<li><a href="http://blast.ncbi.nlm.nih.gov" title=" Tool for finding local regions of sequence similarity ">BLAST (Basic Local Alignment Search Tool)</a></li>
<li><a href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer ">BLAST (Stand-alone)</a></li>
<li><a href="/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences ">BLAST Link (BLink)</a></li>
<li><a href="/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence ">Conserved Domain Search Service (CD Search)</a></li>
<li><a href="/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome ">Genome ProtMap</a></li>
<li><a href="/projects/gbench/" title=" Stand-alone application for analyzing sequence data ">Genome Workbench</a></li>
<li><a href="/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project ">Influenza Virus</a></li>
<li><a href="/tools/primer-blast" title=" Designs PCR primers and analyzes them for target specificity using BLAST. ">Primer-BLAST</a></li>
<li><a href="/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA ">ProSplign</a></li>
<li><a href="/sutils/splign" title=" Tool for aligning transcripts to genomic DNA ">Splign</a></li>
<li><a href="/guide/sequence-analysis/">All Sequence Analysis Resources...</a></li>
</ul>
</li>
<li>
<a href="#taxonomy">Taxonomy</a><ul class="actual-resources-submenu taxonomy">
<li><a href="/taxonomy" title=" The NCBI taxonomy tree in Entrez ">Taxonomy</a></li>
<li><a href="/Taxonomy/Browser/wwwtax.cgi?mode=Root" title=" Displays and links Entrez data to each taxonomic node ">Taxonomy Browser</a></li>
<li><a href="/Taxonomy/CommonTree/wwwcmt.cgi" title=" Creates custom taxonomic trees ">Taxonomy Common Tree</a></li>
<li><a href="/guide/taxonomy/">All Taxonomy Resources...</a></li>
</ul>
</li>
<li>
<a href="#training-tutorials">Training &amp; Tutorials</a><ul class="actual-resources-submenu training-tutorials">
<li><a href="/education/" title=" Central page providing links to tutorials and training materials ">NCBI Education Page</a></li>
<li><a href="/books/NBK21101/" title=" Introductory articles about NCBI resources ">NCBI Handbook</a></li>
<li><a href="/books/NBK3831/" title=" Online, searchable help documentation ">NCBI Help Manual</a></li>
<li><a href="/books/NBK1969/" title=" NCBI's monthly newsletter ">NCBI News</a></li>
<li><a href="/About/primer/" title=" An introduction to bioinformatics at NCBI ">Science Primer</a></li>
<li><a href="/guide/training-tutorials/">All Training &amp; Tutorials Resources...</a></li>
</ul>
</li>
<li>
<a href="#variation">Variation</a><ul class="actual-resources-submenu variation">
<li><a href="/dbvar" title=" A database of genomic structural variation ">Database of Genomic Structural Variation (dbVar)</a></li>
<li><a href="/gap" title=" Genotype/Phenotype association studies ">Database of Genotypes and Phenotypes (dbGaP)</a></li>
<li><a href="/snp" title=" Database of nucleotide sequence polymorphisms ">Database of Single Nucleotide Polymorphisms (dbSNP)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/projects/SNP" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. ">SNP Submission Tool</a></li>
<li><a href="/guide/variation/">All Variation Resources...</a></li>
</ul>
</li>
</ul>
</li>
<li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first">
<a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor" href="/guide/all/#howto_">How To</a><ul id="howto-submenu">
<li><a href="/guide/all/#howto">All How To</a></li>
<li><a href="/guide/chemicals-bioassays/#howto_">Chemicals &amp; Bioassays</a></li>
<li><a href="/guide/dna-rna/#howto_">DNA &amp; RNA</a></li>
<li><a href="/guide/data-software/#howto_">Data &amp; Software</a></li>
<li><a href="/guide/domains-structures/#howto_">Domains &amp; Structures</a></li>
<li><a href="/guide/genes-expression/#howto_">Genes &amp; Expression</a></li>
<li><a href="/guide/genetics-medicine/#howto_">Genetics &amp; Medicine</a></li>
<li><a href="/guide/genomes-maps/#howto_">Genomes &amp; Maps</a></li>
<li><a href="/guide/homology/#howto_">Homology</a></li>
<li><a href="/guide/literature/#howto_">Literature</a></li>
<li><a href="/guide/proteins/#howto_">Proteins</a></li>
<li><a href="/guide/sequence-analysis/#howto_">Sequence Analysis</a></li>
<li><a href="/guide/taxonomy/#howto_">Taxonomy</a></li>
<li><a href="/guide/training-tutorials/#howto_">Training &amp; Tutorials</a></li>
<li><a href="/guide/variation/#howto_">Variation</a></li>
</ul>
</li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                content</a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                navigation</a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li>
</ul>
<div class="myncbi">
<a href="/sites/myncbi/" title="My NCBI" id="myncbiusername"></a><a href="/sites/myncbi/" title="My NCBI">My NCBI</a><a href="/sites/myncbi/" title="Sign in" id="sign_in">Sign In</a><a href="/sites/myncbi/signout/" title="Sign Out" id="sign_out">Sign Out</a>
</div>
</div>
</div>    

        <div class="header">
          
          <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br><a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
          

          
          
  <div class="search">
    <label for="term" class="offscreen_noflow">Search term</label>
    <label for="entrez-search-db" class="offscreen_noflow">Search database</label>
    <div class="search_form">
      <div class="nowrap">
        <div class="nowrap">
          </div>
        
      </div>
    </div>
    <ul class="searchlinks inline_list">
<li>
            <a href="/pmc/limits/">Limits</a>
          </li>
      <li>
            <a href="/pmc/advanced/">Advanced</a>
          </li>
      <li>
            <a href="/pmc/journals/">Journal list</a>
          </li>
      <li class="help">
            <a target="_blank" href="/books/NBK3825/">Help</a>
          </li>
    </ul>
</div>


          
          
          
          
          
        </div>

        
        
        


        <div id="maincontent">
          <div class="col eight_col">
            <div class="navlink-box"><ul class="page-breadcrumbs inline_list small">
<li class="journal-list">
<a href="/pmc/journals/" class="navlink">Journal List</a> &gt;</li>
<li class="archive-page">
<a class="navlink" href="/pmc/journals/101/">Genes Dev</a> &gt;</li>
<li class="issue-page">
<a class="navlink" href="/pmc/issues/9365/">v.13(1); Jan 1, 1999</a> &gt;</li>
<li class="accid">PMC316375</li>
</ul></div>
            
            <div class="pmc-page-banner whole_rhythm">
<div>
<img align="top" src="/corehtml/pmc/pmcgifs/logo-genesdev.gif" alt="Logo of genesdev" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="default" alt="Genes &amp; Development" href="http://www.genesdev.org" target="pmc_ext">
<area shape="rect" coords="0,58,94,74" href="http://www.cshlpress.com/" alt="CSHL Press" title="CSHL Press" target="pmc_ext">
<area shape="rect" coords="95,58,196,74" href="http://www.genesdev.org" alt="Journal Home" title="Journal Home" target="pmc_ext">
<area shape="rect" coords="197,58,298,74" href="http://www.genesdev.orgsite/subscriptions/" alt="Subscriptions" title="Subscriptions" target="pmc_ext">
<area shape="rect" coords="299,58,390,74" href="http://genesdev.cshlp.org/site/misc/aboutcca.xhtml" alt="eTOC Alerts" title="eTOC Alerts" target="pmc_ext">
<area shape="rect" coords="391,58,499,74" href="http://www.biosupplynet.com/" alt="BioSupplyNet" title="BioSupplyNet" target="pmc_ext"></map>
</div> </div>

            
            
            <div class="hide-overflow article lit-style content pmc-wm page-box">
<div class="jig-ncbiinpagenav">
<div class="fm-sec half_rhythm no_top_margin">
<div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small">
<div class="inline_block nine_col va_top"><div>
<div>
<span class="citation-version"></span><span class="citation-abbreviation">Genes Dev. </span><span class="citation-publication-date">1999 January 1; </span><span class="citation-volume">13</span><span class="citation-issue">(1)</span><span class="citation-flpages">: 64–75. </span>
</div>
<div>  </div>
</div></div>
<div class="inline_block three_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid">
<span class="fm-citation-ids-label">PMCID: </span><span>PMC316375</span>
</div></div></div>
</div></div>
<h1 class="content-title">Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1</h1>
<div class="half_rhythm"><div class="contrib-group fm-author">
<a href="/sites/entrez?cmd=search&amp;db=PubMed&amp;term=%20Bhattacharya%2BS%5Bauth%5D">Shoumo Bhattacharya</a>,<sup>1</sup><a href="/sites/entrez?cmd=search&amp;db=PubMed&amp;term=%20Michels%2BCL%5Bauth%5D">Catherine L. Michels</a>, <a href="/sites/entrez?cmd=search&amp;db=PubMed&amp;term=%20Leung%2BMK%5Bauth%5D">Man-Kit Leung</a>, <a href="/sites/entrez?cmd=search&amp;db=PubMed&amp;term=%20Arany%2BZP%5Bauth%5D">Zoltàn P. Arany</a>, <a href="/sites/entrez?cmd=search&amp;db=PubMed&amp;term=%20Kung%2BAL%5Bauth%5D">Andrew L. Kung</a>, and  <a href="/sites/entrez?cmd=search&amp;db=PubMed&amp;term=%20Livingston%2BDM%5Bauth%5D">David M. Livingston</a><sup>2</sup>
</div></div>
<div class="fm-panel small half_rhythm">
<div class="fm-authors-info fm-panel hide half_rhythm" id="id1582481_ai">
<div class="fm-affl">The Dana-Farber Cancer Institute and the Harvard Medical School, Boston, Massachusetts 02115 USA</div>
<div id="FN1">
<sup>1</sup>Present address: Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.</div>
<div id="FN2">
<sup>2</sup>Corresponding author.</div>
</div>
<div class="togglers">
<a href="">Author information <span>►</span></a> <a href="">Article notes <span>►</span></a> <a href="">Copyright and License information <span>►</span></a>
</div>
<div class="fm-article-notes fm-panel hide half_rhythm" id="id1582481_an"><div class="fm-pubdate half_rhythm">Received August 14, 1998; Accepted November 17, 1998.</div></div>
<div class="fm-cpl-info fm-panel hide half_rhythm" id="id1582481_cpl"><div class="fm-copyright half_rhythm">
<a href="/pmc/about/copyright.html">Copyright</a>  © 1999, Cold Spring Harbor Laboratory Press</div></div>
</div>
<div class="links-box whole_rhythm"><div class="small"><div>This article has been <a href="/pmc/articles/PMC316375/citedby/">cited by</a> other articles in PMC.</div></div></div>
</div>
<div class="sec"></div>
<div id="__abstractid1561827" class="sec">
<h2 class="head no_bottom_margin" id="__abstractid1561827title">Abstract</h2>
<div><p id="__p3">Recruitment of p300/CBP by the hypoxia-inducible factor, HIF-1, is essential for the transcriptional response to hypoxia and requires an interaction between the p300/CBP CH1 region and HIF-1α. A new p300-CH1 interacting protein, p35srj, has been identified and cloned. p35srj is an alternatively spliced isoform of MRG1, a human protein of unknown function. Virtually all endogenous p35srj is bound to p300/CBP in vivo, and it inhibits HIF-1 transactivation by blocking the HIF-1α/p300 CH1 interaction. p35srj did not affect transactivation by transcription factors that bind p300/CBP outside the CH1 region. Endogenous p35srj is up-regulated markedly by the HIF-1 activators hypoxia or deferoxamine, suggesting that it could operate in a negative-feedback loop. In keeping with this notion, a p300 CH1 mutant domain, defective in HIF-1 but not p35srj binding, enhanced endogenous HIF-1 function. In hypoxic cells, p35srj may regulate HIF-1 transactivation by controlling access of HIF-1α to p300/CBP, and may keep a significant portion of p300/CBP available for interaction with other transcription factors by partially sequestering and functionally compartmentalizing cellular p300/CBP.</p></div>
<div class="sec">
<strong class="kwd-title">Keywords: </strong><span class="kwd-text">Hypoxia, HIF-1, transcription, p35srj, p300, CBP, regulation</span>
</div>
</div>
<div id="__bodyid1561865" class="sec headless whole_rhythm">
<p id="__p4">Localized tissue hypoxia is a major factor in the pathogenesis of tumor vascularization, myocardial ischemia, and stroke. An hypoxic signal is transduced through a hemoprotein oxygen sensor and results in the induction of the transcription factor, hypoxia inducible factor-1 (HIF-1). HIF-1 consists of HIF-1α and ARNT (aryl hydrocarbon nuclear translocator) subunits (<a href="/pubmed/7539918" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734080">Wang et al. 1995</a>; for review, see <a href="/pubmed/9094708" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734068">Guillemin and Krasnow 1997</a>). Hypoxia results in the stabilization of the HIF-1α protein, a marked increase in its transactivation potential, and heterodimerization of HIF-1α with ARNT to form active HIF-1 (<a href="/pubmed/8702901" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734072">Li et al. 1996</a>; <a href="/pubmed/9235919" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734054">Jiang et al. 1997</a>; <a href="/pubmed/9159130" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734094">Kallio et al. 1997</a>; <a href="#B27" class="cite-reflink bibr popnode">Pugh 1997</a>; <a href="/pubmed/9653127" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734053">Huang et al. 1998</a>). The active HIF-1 heterodimer binds to its cognate response element and activates transcription of several hypoxia-induced genes, including those encoding erythropoietin, vascular endothelial growth factor (VEGF), and key glycolytic enzymes. HIF-1α deficiency results in embryonic lethality, with severe neurological and cardiovascular developmental abnormalities and impaired expression of HIF-1 target genes. This suggests that HIF-1α is a global regulator of developmental and cellular O<sub>2</sub> homeostasis (<a href="/pubmed/9436976" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734069">Iyer et al. 1998</a>).</p>
<p id="__p5">HIF-1α activates transcription by recruiting the transcriptional adapter/histone acetyltransferase proteins, p300 and CBP (CREB-binding protein), to a transcription complex. This is essential for the normal cellular response to hypoxia (<a href="/pubmed/8917528" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734071">Arany et al. 1996</a>). p300 and CBP (Fig.1A) are homologous, ubiquitously expressed, nuclear phosphoproteins that contain three highly conserved cysteine–histidine-rich domains (CH1, -2, and -3). p300/CBP function as coactivators, linking signal-responsive DNA-bound transcriptional activators to the basal transcription machinery. It is likely that they also modify chromatin structure by virtue of intrinsic and associated (P/CAF, P/CIP-ACTR, src1) histone acetyltransferase activities (for review, see <a href="#B30" class="cite-reflink bibr popnode">Shikama et al. 1997</a>).  </p>
<p id="__p6">The CH1 region of p300 binds HIF-1α (<a href="/pubmed/8917528" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734077">Arany et al. 1996</a>) and STAT2 directly (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734082">Bhattacharya et al. 1996</a>), linking this region, at a minimum, to hypoxia and interferon-α signal transduction. The p300 CH1 domain is also important for the binding of the transcription factor ets-1 (<a href="/pubmed/9528793" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734043">Yang et al. 1998</a>), the NFκB p65 subunit (<a href="#B40" class="cite-reflink bibr popnode">Zhong et al. 1998</a>), p53, and MDM2 (<a href="#B10" class="cite-reflink bibr popnode">Grossman et al. 1998</a>). A 35-kD cellular protein that binds p300-CH1 strongly was identified in our laboratory. We have cloned a human cDNA encoding this protein using an expression screen in which the p300-CH1 domain served as probe and named it p35srj for its unusual <span class="underline">s</span>erine-glycine <span class="underline">r</span>ich <span class="underline">j</span>unction. p35srj is a novel p300/CBP binding protein, and is an alternatively spliced isoform of MRG1 (<a href="/pubmed/8901575" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734062">Shioda et al. 1996</a>), a human protein of unknown function. Here we provide data indicating that p35srj is the product of a HIF-1-regulated gene, that functions, at least in part, to regulate access of HIF-1α and other CH1-binding proteins to p300/CBP and could serve to partition p300/CBP into functionally discrete subsets.</p>
</div>
<div id="__sec1" class="sec">
<h2 class="head no_bottom_margin" id="__sec1title">Results</h2>
<div id="__sec2" class="sec sec-first">
<h3>Expression cloning of human p35srj, a highly conserved p300-CH1 binding<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">protein</h3>
<p id="__p7">A HeLa λgt11 expression library was screened with a probe consisting of <sup>32</sup>P labeled glutathione S-transferase fused to the CH1 domain of p300 (GST–CH1), as described previously (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734042">Bhattacharya et al. 1996</a>). In addition to clones for STAT2 and HIF-1α (encoding amino acid residues 723-826), a single clone encoding a novel peptide was obtained. A full-length clone was obtained by screening a 293λZAP library with this cDNA. The open reading frame of this clone predicted the synthesis of a 270-amino acid polypeptide (Fig. <a href="/pmc/articles/PMC316375/figure/F1/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.1B).</span></span><span>1</span></a>B). In vitro-translated clonal p35srj comigrated with and had a similar peptide map to endogenous p35 present in anti-p300/CBP immunoprecipitates (data not shown). The murine p35srj peptide sequence (Fig. <a href="/pmc/articles/PMC316375/figure/F1/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.1B)</span></span><span>1</span></a>B) was deduced by cloning and sequencing murine genomic p35srj (S. Bhattacharya and D.M. Livingston, unpubl.). It and the human sequence are very similar (94.8% identity). Human and murine p35srj peptide sequences revealed an unusual, conserved 39-amino acid serine–glycine-rich junction (srj). p35srj does not contain a known DNA-binding domain or other known protein motifs.</p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F1">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F1/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f1.gif" class="small-thumb" alt="Figure 1" title="Figure 1"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F1/" target="figure">Figure 1</a></h4>
<div>
<span>Cloning, expression, and stability of p35srj. (<em>A</em>) p300 and CBP contain multiple, conserved regions. These include three cysteine–histidine rich regions (CH1–3), the KIX domain (which binds CREB), a bromodomain, and a glutamine-rich region.</span><a href="/pmc/articles/PMC316375/figure/F1/"> (more ...)</a>
</div>
</div>
</div>
<p id="__p8">Database searches indicated that p35srj is similar to the products of two related human genes of unknown function, <em>MRG1</em>, and <em>MSG1</em> (<a href="/pubmed/8901575" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734093">Shioda et al. 1996</a>). <em>MRG1</em> is an alternatively spliced isoform of p35srj that lacks the conserved serine–glycine rich junction. Comigration of in vitro translated, clonal p35srj with the endogenous immunoprecipitated protein indicates that the major endogenous isoform is p35srj (data not shown). As pointed out previously (<a href="/pubmed/8901575" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734049">Shioda et al. 1996</a>), p35srj/MRG1 and MSG1 have similar carboxyl termini (76% identity over 45 amino acids). Because all data herein refer to the isoform containing the serine-rich junction, we will use the term p35srj. A search of the <em>Fugu rubripes</em> database also identified a DNA sequence encoding a protein fragment with strong (76.3% identity over 38 amino acids) homology to p35srj (Fig. <a href="/pmc/articles/PMC316375/figure/F1/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.1B).</span></span><span>1</span></a>B). p35srj homologs have not been found in the <em>Saccharomyces cerevisiae</em>, <em>Caenorhabditis elegans</em>, or <em>Drosophila</em> databases.</p>
</div>
<div id="__sec3" class="sec">
<h3>p35srj is an unstable nuclear protein that is almost entirely bound to<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">p300/CBP</h3>
<p id="__p9">Northern blots of mRNA from multiple human tissues revealed that p35srj is ubiquitously expressed (Fig. <a href="/pmc/articles/PMC316375/figure/F1/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.1C),</span></span><span>1</span></a>C), like p300 and CBP (<a href="/pubmed/7523245" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734048">Eckner et al. 1994</a>). Western blots probed with anti-p35srj polyclonal and monoclonal antibodies showed that the protein is present in all human and murine cell lines examined (data not shown). p35srj is unstable, with a half-life of ∼20 min (Fig. <a href="/pmc/articles/PMC316375/figure/F1/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.1D).</span></span><span>1</span></a>D). Immunostaining with anti-p35srj monoclonal antibody revealed that endogenous and ectopically expressed p35srj is nuclear in U2-OS and other cell lines studied (Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.2</span></span><span>2</span></a> and data not shown). Endogenous p35srj colocalized with p300 in dot-like structures that are detected when p300 is ectopically overproduced (<a href="/pubmed/7523245" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734074">Eckner et al. 1994</a>; Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Fig.2C).</span></span><span>2</span></a>C).  </p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F2">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F2/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f2.gif" class="small-thumb" alt="Figure 2" title="Figure 2"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F2/" target="figure">Figure 2</a></h4>
<div>
<span>p35srj is a nuclear protein bound to p300/CBP. (<em>A</em>) Cellular localization of endogenous p35srj. U2-OS cells were stained with Hoechst to demonstrate cell nuclei, and with anti-p35srj monoclonal antibody JA22, to demonstrate endogenous p35srj. (<em>B</em>) U2-OS</span><a href="/pmc/articles/PMC316375/figure/F2/"> (more ...)</a>
</div>
</div>
</div>
<p id="__p10">Monoclonal anti-p300/CBP (AC240) immunoprecipitates contained high levels of endogenous p35srj (Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.2D,</span></span><span>2</span></a>D, lane 5). AC240 did not cross react with p35srj (data not shown), and p35srj was not detected in the control antibody immunoprecipitates. These data suggest that the two proteins interact in vivo. In this regard, AC240, which recognizes both p300 and CBP, coprecipitated p35srj just as well as an anti-p35srj monoclonal antibody (cf. Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Fig.2D,</span></span><span>2</span></a>D, lanes 1 and 5) implying that complex formation is an efficient process. In this regard, we found that AC240 immunoabsorption of p300/CBP depleted most of the p35srj in a U20S lysate at 150 m<span class="small-caps">m</span> NaCl (Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.2D,</span></span><span>2</span></a>D, lane 10). The p35srj/p300 interaction was less stable in the presence of high (300 m<span class="small-caps">m</span> NaCl) salt-containing buffer (Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.2D,</span></span><span>2</span></a>D, lane 4).Taken together, these results imply that nearly all steady-state p35srj is bound to p300/CBP.</p>
<p id="__p11">Immunoprecipitation with the anti-p35srj mAb, JA22, also recovered significant amounts of endogenous p300/CBP, although the recovery of the latter was incomplete (Fig. <a href="/pmc/articles/PMC316375/figure/F2/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.2E).</span></span><span>2</span></a>E). This suggests that a significant fraction of the ambient p300/CBP is not complexed to p35srj.</p>
</div>
<div id="__sec4" class="sec">
<h3>Carboxy-terminal residues of p35srj are sufficient for binding to<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">p300-CH1</h3>
<p id="__p12">To map the p35srj structures necessary for binding to p300-CH1, we constructed expression vectors encoding HA and VP16 activation domain-tagged wild-type and deletion mutant p35srj species. These vectors were used to synthesize <sup>35</sup>S-labeled proteins by in vitro translation. Binding of these polypeptides to GST–p300 was then assayed (Fig. <a href="/pmc/articles/PMC316375/figure/F3/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.3A).</span></span><span>3</span></a>A). These experiments showed the carboxy-terminal region of p35srj, extending between residues 215 and 270, was necessary for p300–CH1 binding. To define the minimal binding region, discrete segments of the 215–270 region were fused to green fluorescent protein (as carrier) and assayed for GST–p300–CH1 binding (Fig. <a href="/pmc/articles/PMC316375/figure/F3/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.3B).</span></span><span>3</span></a>B). A region of 32 amino acids (224–255) was required for this reaction. When synthesized as a peptide, it efficiently competed with p35srj for binding to p300–CH1 (Fig. <a href="/pmc/articles/PMC316375/figure/F3/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.3C),</span></span><span>3</span></a>C), indicating that it is also sufficient for this interaction. Notably this peptide sequence is highly conserved in MSG1.  </p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F3">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F3/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f3.gif" class="small-thumb" alt="Figure 3" title="Figure 3"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F3/" target="figure">Figure 3</a></h4>
<div>
<span>p35srj carboxy-terminal residues are required for CH1 binding. (<em>A</em>) Binding of <sup>35</sup>S-labeled, in vitro translated p35srj derivatives to GST or GST–p300CH1 fusion proteins (lanes <em>1–6</em>). Twenty percent of the in vitro-translated input was loaded</span><a href="/pmc/articles/PMC316375/figure/F3/"> (more ...)</a>
</div>
</div>
</div>
<p id="__p13">The ability of various VP16–p35srj fusion proteins to interact with E2–p300 (p300 fused to the BPV–E2 DNA-binding domain) in vivo was tested in a mammalian two-hybrid assay (Fig. <a href="/pmc/articles/PMC316375/figure/F3/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.3D).</span></span><span>3</span></a>D). In keeping with the above-noted results, the data show that the carboxy-terminal region of p35srj is also essential for an in vivo p35srj/p300 interaction. In return, the CH1 domain is required for efficient binding of this carboxy-terminal p35srj sequence to p300 in vivo (see Fig. <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Fig.4D).</span></span><span>4</span></a>D).  </p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F4">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F4/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f4.gif" class="small-thumb" alt="Figure 4" title="Figure 4"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F4/" target="figure">Figure 4</a></h4>
<div>
<span>p35srj competes with HIF-1α for binding to p300–CH1 in vitro and in vivo. (<em>A</em>) Effect of baculoviral p35srj on in vitro binding of HIF-1α to p300–CH1. (<em>Top</em>) The binding of <sup>35</sup>S-labeled HIF-1α (lane <em>1</em>) generated by</span><a href="/pmc/articles/PMC316375/figure/F4/"> (more ...)</a>
</div>
</div>
</div>
</div>
<div id="__sec5" class="sec">
<h3>p35srj competes with HIF-1α for binding to p300-CH1 in vitro and in<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">vivo</h3>
<p id="__p14">Because HIF-1α and p35srj both bind directly to the CH1 region, we asked whether they compete with one another for CH1 complex formation. As shown in Figure <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Figure4A</span></span><span>4</span></a>A (lane 4), baculovirus-encoded p35srj competed with HIF-1α efficiently for binding to p300–CH1 in vitro, whereas a mutant protein lacking its p300-binding domain failed in this regard. Similarly, the p35srj 32mer peptide competed with intact HIF-1α for CH1 binding (Fig. <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.4C,</span></span><span>4</span></a>C, lanes 5–7).</p>
<p id="__p15">HIF-1α has two transactivation domains. The amino-terminal one (TAD-N) overlaps an oxygen-dependent degradation domain and accounts for the instability of HIF-1α under normoxic conditions (<a href="/pubmed/9653127" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734040">Huang et al. 1998</a>). The carboxy-terminal one (TAD-C) is only weakly active under normoxic conditions, but is induced markedly by hypoxia or the hypoxia mimic, deferoxamine (DFO), without there being any change in protein level (<a href="/pubmed/8702901" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734086">Li et al. 1996</a>; <a href="/pubmed/9235919" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734098">Jiang et al. 1997</a>; <a href="/pubmed/9159130" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734091">Kallio et al. 1997</a>; <a href="#B27" class="cite-reflink bibr popnode">Pugh 1997</a>; <a href="/pubmed/9653127" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734084">Huang et al. 1998</a>). The results of our expression cloning screen (see earlier discussion) and of in vitro binding assays indicated that HIF-1α residues 723–826, which overlap TAD-C, but not TAD-N, bind p300–CH1.</p>
<p id="__p16">To test whether p35srj interferes with the binding of HIF-1α to p300–CH1 in vivo, we used a mammalian two-hybrid assay (Fig. <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.4D,E).</span></span><span>4</span></a>D,E). First, GAL4–p300–CH1 was coexpressed with VP16–HIF1α TAD-C (residues 723–826) in Hep3B cells along with a GAL4-luciferase reporter. Under normoxic conditions, there was no evidence of an interaction between the two proteins relative to the control VP16 vector (Fig. <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.4D).</span></span><span>4</span></a>D). Stimulation with deferoxamine led to a threefold activation over control, indicating the development of a specific interaction. This two-hybrid interaction depended on both the VP16 and HIF-1α components of the fusion protein, since a HIF-1α species lacking the VP16 domain did not have this effect (data not shown). No interaction was detected between VP16–HIF-1α and GAL4–CH11Δ, a mutant derivative lacking an intact CH1 domain.</p>
<p id="__p17">The effect of cotransfected p35srj on the interaction between GAL4–p300–CH1, and VP16–HIF-1α was then assayed. As seen in Figure <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Figure4E,</span></span><span>4</span></a>E, with cotransfection of a vector control or a p35srj1Δ expression vector (lacking residues 215–270), there was a 3.7-fold induction of the two-hybrid interaction by deferoxamine. Cotransfection of p35srj reduced this substantially (Fig. <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.4E).</span></span><span>4</span></a>E). Notably, the apparent affinity of VP16–p35srj for p300–CH1 was not affected by deferoxamine stimulation and was at least 10-fold greater than that of VP16–HIF-1α (see Fig. <a href="/pmc/articles/PMC316375/figure/F4/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Fig.4D).</span></span><span>4</span></a>D). Hence, the inhibitory effect of p35srj likely occurred independently of any increase in intrinsic ability of p35srj to bind to CH1.</p>
</div>
<div id="__sec6" class="sec">
<h3>p35srj inhibits HIF-1 transactivation</h3>
<p id="__p18">Fusion of HIF-1α residues 723–826 (TAD-C) to a GAL4–DNA-binding domain (GAL4–HIF-1α) permitted specific assays of its transcription function. Whereas GAL4–HIF-1α is a weak transcriptional activator under normoxic conditions, it was strongly activated by the hypoxia mimic, deferoxamine, without any change in protein level (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5A).</span></span><span>5</span></a>A). Deletion of its carboxy-terminal 13 residues (GAL4–HIF1-αΔ) resulted in complete loss of transactivation. These results are consistent with those reported previously (<a href="/pubmed/8702901" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734056">Li et al. 1996</a>; <a href="/pubmed/9235919" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734039">Jiang et al. 1997</a>; <a href="#B27" class="cite-reflink bibr popnode">Pugh 1997</a>). Transactivation correlated with p300 binding, because deletion of the carboxy-terminal 13 residues of GAL4–HIF1α also resulted in complete loss of p300–CH1 binding (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5B).</span></span><span>5</span></a>B).  </p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F5">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F5/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f5.gif" class="small-thumb" alt="Figure 5" title="Figure 5"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F5/" target="figure">Figure 5</a></h4>
<div>
<span>p35srj inhibits HIF-1 transactivation by specifically affecting CH1 function. (<em>A</em>) Effect of p35srj on the activation of a GAL4–luciferase reporter by GAL4–HIF-1α (723–826). (<em>Top</em>) Hep3B cells were transiently cotransfected</span><a href="/pmc/articles/PMC316375/figure/F5/"> (more ...)</a>
</div>
</div>
</div>
<p id="__p19">Cotransfection of an HA-tagged p35srj wild-type expression plasmid led to marked inhibition of both basal normoxic and deferoxamine induced GAL4–HIF1α transcriptional activity, without affecting its abundance (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5A).</span></span><span>5</span></a>A). A p35srj mutant lacking its p300–CH1 binding domain (HA–p35srjΔ) and present in similar amounts did not affect GAL4–HIF1α function. Induction of TAD-C transactivation by hypoxia was inhibited similarly by p35srj (data not shown). These results indicate that p35srj can interfere with HIF-1α TAD-C function. Taken together with the previous data, these results indicate that the affinity of HIF-1α for p300–CH1 increases with deferoxamine stimulation, and that p35srj inhibits HIF-1 transactivation function by interfering with the access of HIF-1α TAD-C to p300/CBP–CH1.</p>
<p id="__p20">We next asked whether p35srj inhibits the activation of a natural HIF-1 response element by deferoxamine (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5C).</span></span><span>5</span></a>C). The vascular endothelial cell growth factor promoter (pVEGF) fused to luciferase was used as a reporter of endogenous HIF-1 activity. This element contains a HIF-1 response element (<a href="/pubmed/7768934" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734081">Levy et al. 1995</a>), is markedly activated by deferoxamine, and its activation was suppressed by p35srj, but not by HA–p35srjΔ. P35srj had no effect on basal activity of pVEGF–luciferase, indicating that p35srj effects are specific to deferoxamine activation of HIF-1. Induction of pVEGF–luciferase activity by hypoxia was also inhibited by p35srj (data not shown). Taken together, these results suggest that p35srj-mediated suppression of the interaction of p300/CBP with HIF-1α TAD-C resulted in inhibition of HIF-1 transactivation.</p>
</div>
<div id="__sec7" class="sec">
<h3>p35srj specifically inhibits p300–CH1 interacting<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">transactivators</h3>
<p id="__p21">To determine whether p35srj is a general repressor of p300/CBP function, we tested its effect on three other p300/CBP interacting transcription factors: (1) STAT2, which binds CH1 (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734088">Bhattacharya et al. 1996</a>); (2) SREBP2, which binds the KIX domain (<a href="/pubmed/8918891" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734057">Oliner et al. 1996</a>); and (3) src-1, which interacts with the glutamine-rich domain (<a href="/pubmed/8855229" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734051">Yao et al. 1996</a>). p35srj specifically inhibited transcription by GAL4–HIF-1α and GAL4–STAT2, but not by SREBP2 or src-1 (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5D,E).</span></span><span>5</span></a>D,E). Moreover, p35srj competed with STAT2 for binding to p300–CH1 in vitro (data not shown). These results imply that p35srj specifically affects at least two p300–CH1-mediated events.</p>
</div>
<div id="__sec8" class="sec">
<h3>p35srj is induced by deferoxamine and<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">hypoxia</h3>
<p id="__p22">We next asked whether p35srj is, itself, affected by HIF-1 activation. Surprisingly, we found that, in Hep3B cells, hypoxia or deferoxamine, both activators of HIF-1, strongly induced synthesis of <em>p35srj</em> mRNA and protein, which resulted in the formation of p300/CBP–p35srj complexes. The latter reached a plateau between 1 and 6 hr after initiating the stimulus (Fig. <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.6A),</span></span><span>6</span></a>A), and could be detected by both anti-p300/CBP (Fig. <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.6A)</span></span><span>6</span></a>A) as well as anti-p35srj monoclonal antibodies (Fig. <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.6B).</span></span><span>6</span></a>B). We noted that p35srj protein level appeared to peak before the mRNA. Possible mechanisms for this include changes in synthesis and degradation rates at different time points. Pulse-chase experiments indicated that whereas p35srj protein synthesis was markedly upregulated by deferoxamine at 5 hr, there did not appear to be any significant effect on stability (data not shown). It is possible that at later time points either the protein synthesis rate falls, or that the degradation rate rises.  </p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F6">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F6/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f6.gif" class="small-thumb" alt="Figure 6" title="Figure 6"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F6/" target="figure">Figure 6</a></h4>
<div>
<span>p35srj is induced by deferoxamine and hypoxia. (<em>A</em>) Hep3B cells were grown to confluence and exposed to either 1 or 21% O<sub>2</sub> for 6 hr or to 100 μ<span class="small-caps">m</span> DFO for the indicated periods of time. Total RNA from these cells was Northern blotted and</span><a href="/pmc/articles/PMC316375/figure/F6/"> (more ...)</a>
</div>
</div>
</div>
<p id="__p23">These experiments suggested that p35srj may be transcriptionally regulated by HIF-1. To investigate this further, we cloned and sequenced ∼3.5 kb of the human <em>p35srj</em> promoter. Three consensus HIF-1 response elements (HREs, 5′-RCGTG) (<a href="/pubmed/8786149" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734096">Semenza et al. 1996</a>) were identified in tandem within a 32 nucleotide sequence of the p35srj promoter (−1196/−1165, relative to the start of <em>p35srj</em> cDNA). A human <em>p35srj</em> promoter–luciferase reporter plasmid (−2186/+65), containing the 3× HRE, was constructed. Reporter activity from this plasmid was activated about fourfold by deferoxamine (Fig. <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.6C).</span></span><span>6</span></a>C). A deletion mutant reporter (−973/+65), lacking the 3× HRE, was not activated. A short promoter segment within which the 3× HRE sequence is imbedded, (−1202/−1159), when cloned upstream of a <em>HSV–TK</em> minimal promoter–luciferase reporter, resulted in similar inducibility by deferoxamine.</p>
<p id="__p24">Gel-shift analysis showed that a <sup>32</sup>P-labeled, 3× HRE sequence from the <em>p35srj</em> promoter specifically formed a  complex with HIF-1 (i.e., HIF-1α<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">+<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">ARNT, Fig. <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Fig.6D,</span></span><span>6</span></a>D, lane 5), but not with either protein individually (lanes 1 and 3). Formation of this complex was specifically competed by excess, cold wild-type HIF-1 binding oligonucleotide (W18, lane 7), but not by a mutant oligonucleotide (M18, lane 9) (<a href="/pubmed/7836384" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734045">Wang and Semenza 1995</a>). A mutant 3× HRE probe from the <em>p35srj</em> promoter did not bind HIF-1 (lane 6).</p>
<p id="__p25">These results show that p35srj is transcriptionally induced by hypoxia and deferoxamine, and that this induction could be mediated by HIF-1. Taken together with the previous results, they suggest that p35srj can function in a negative-feedback mechanism to regulate HIF-1 transactivation.</p>
</div>
<div id="__sec9" class="sec sec-last">
<h3>Sequestration of endogenous p35srj enhances endogenous HIF-1 function in<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">vivo</h3>
<p id="__p26">To explore the function of endogenous p35srj, we attempted to specifically titrate endogenous p35srj (but not HIF-1α) away from endogenous p300/CBP. In preparation for such an experiment, a systematic linker scanning mutagenesis, replacing six consecutive amino acid residues of the p300–CH1 region with the peptide sequence, NAAIRS, was performed (A.L. Kung and D.M. Livingston, unpubl.). The NAAIRS linker can assume an α-helical or a β-sheet configuration, thereby minimally affecting protein folding when inserted at the site of a small deletion (<a href="/pubmed/8415675" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734097">Wilson et al. 1993</a>; <a href="/pubmed/9420334" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734090">Sellers et al. 1998</a>). A mutation replacing p300 amino acids 413–418 resulted in a mutant CH1 protein that bound tightly to in vitro translated p35srj, but was completely defective for binding to HIF-1α (Fig. <a href="/pmc/articles/PMC316375/figure/F7/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.7A).</span></span><span>7</span></a>A). A mutation that replaced p300 residues 371–376 bound very weakly to p35srj but, like CH1 413–418, appeared to be wholly defective for binding HIF-1α. We assayed the effects of overproducing these mutant p300–CH1 domains on the response of the VEGF promoter to DFO. Importantly, neither p35srj, nor HIF-1α, nor intact p300 were transfected in this experiment. As shown in Figure <a href="/pmc/articles/PMC316375/figure/F7/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Figure7B,</span></span><span>7</span></a>B, in the presence of both mutant p300–CH1 domains, there was clear DFO activation of the VEGF promoter. However, by comparison with the effect noted in cells cotransfected with the mutant CH1 species that bound p35srj poorly (CH1 371–376), a net increase in DFO-mediated pVEGF activation was observed repeatedly in the presence of the CH1 413–418 mutant, which strongly and specifically binds p35srj. These results imply that specific sequestration of endogenous p35srj by an ectopic CH1-containing polypeptide leads to enhanced activation of the VEGF promoter by endogenous HIF-1, which, in turn, was activated by deferoxamine. Hence, one can argue that p35srj participates in the modulation of an endogenous HIF-1 response to hypoxia or an equivalent, deferoxamine exposure.  </p>
<div class="fig iconblock ten_col whole_rhythm clearfix" id="F7">
<a class="img_link icnblk_img figpopup" href="/pmc/articles/PMC316375/figure/F7/" target="figure"><img src="/pmc/articles/PMC316375/bin/gad.8f7.gif" class="small-thumb" alt="Figure 7" title="Figure 7"></a><div class="icnblk_cntnt">
<h4><a href="/pmc/articles/PMC316375/figure/F7/" target="figure">Figure 7</a></h4>
<div>
<span>Sequestering p35srj enhances HIF-1 transactivation. (<em>A</em>) Effect of mutations in GST p300–CH1 on binding to HIF-1α and to p35srj. GST–CH1 wild type includes p300 amino acids 300–528. In GST–CH1–371–6,</span><a href="/pmc/articles/PMC316375/figure/F7/"> (more ...)</a>
</div>
</div>
</div>
</div>
</div>
<div id="__sec10" class="sec">
<h2 class="head no_bottom_margin" id="__sec10title">Discussion</h2>
<p id="__p27">A novel, p300–CH1 interacting protein, p35srj, was cloned by an expression strategy. It is ubiquitously expressed, unstable, nuclear, and almost entirely bound directly to p300/CBP in vivo. However, most p300/CBP is apparently uncomplexed with p35srj, implying that variations in the p35srj protein level could, in principle, alter the level of free p300/CBP.</p>
<p id="__p28">HIF-1α and p35srj bind directly to the p300/CBP-CH1 domain. p35srj blocked the HIF-1α–p300 interaction in vitro and in vivo, suggesting that the mechanisms by which p35srj and HIF-1α bind to p300–CH1 may be related. In keeping with this suggestion, both p35srj and HIF-1α have similar, negatively charged, leucine-rich p300–CH1 binding regions (data not shown). As a small peptide derived from the p35srj carboxy-terminal region also blocked the HIF-1α–p300 interaction, it is likely that the mechanism of the observed competition is direct occupancy of a CH1 binding site(s) rather than steric hindrance. The existence of p300 mutations that discriminate between p35srj and HIF-1α suggest that the two proteins do not occupy the same site on p300. They could however occupy overlapping sites. Alternatively, binding of p35srj might alter p300–CH1 structure, affecting its ability to bind to HIF-1α.</p>
<p id="__p29">The data also suggest strongly that HIF-1α transactivation requires the efficient binding of its carboxyl terminus to p300/CBP–CH1, and that deferoxamine activation of HIF-1α appeared to be associated with marked enhancement of its affinity for p300–CH1. This could result from a conformational change in the HIF-1α carboxy-terminal region. p35srj inhibited basal and deferoxamine-activated HIF-1α carboxy-terminal region transactivation, as well as activation of the VEGF promoter by endogenous HIF-1. As the carboxy-terminal transactivating domain of HIF-1α is hypoxia/deferoxamine-activated, it appears that p35srj can interfere directly with the physiological association of p300/CBP with an important functional domain of HIF-1α TAD-C. Indeed, this increase in affinity and the marked increase in total HIF-1α level resulting from protein stabilization, would allow it to compete more efficiently with the constitutive, seemingly high-affinity CH1-interacting protein, p35srj, for access to limited quantities of p300/CBP. Such a mechanism would allow HIF-1α to recruit p300/CBP into a productive transcription complex, thereby increasing its transactivation potential.</p>
<p id="__p30">Why there are two, independently activated HIF-1α domains is not clear. The amino-terminal transactivation domain (TAD-N) might function through p300/CBP, or it might contact the transcriptional machinery by another route. Conceivably, the two transactivation domains of HIF-1α may be involved in the fine-tuning of the hypoxia response through potential cooperative interactions with other vital components of the transcription machinery. The presence of TAD-N activity might explain why p35srj only partially inhibited HIF-1 transactivation (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5C),</span></span><span>5</span></a>C), as opposed to its more marked inhibition of the carboxy-terminal transactivation domain (Fig. <a href="/pmc/articles/PMC316375/figure/F5/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.5A,D).</span></span><span>5</span></a>A,D). Indeed, we have observed that hypoxia, or deferoxamine activation of GAL4–HIF-1α (401–603) is not inhibited by p35srj (data not shown).</p>
<p id="__p31">Taken together, the results presented in this report lead us to propose the following model (Fig. <a href="/pmc/articles/PMC316375/figure/F7/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">(Fig.7C).</span></span><span>7</span></a>C). Hypoxia, and other activators such as deferoxamine, induce HIF-1α<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">+<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">ARNT complex formation and DNA-binding, and activate the carboxy-terminal transactivation domain of HIF-1α. This results in an increase in the affinity of the HIF-1α carboxyl terminus for p300/CBP–CH1. The increased affinity for CH1 and the increase in HIF-1α protein level allow it to compete more effectively with p35srj, and possibly other CH1-interacting proteins, for binding to CH1. Activated HIF-1α then signals through p300/CBP to the basal transcription complex, leading to the transcription of genes essential for the hypoxic response. These events also lead to increased transcription of p35srj, which is encoded by a gene bearing HIF-1 sites within its promoter. This, in turn, leads to accumulation of p35srj, which complexes with p300/CBP by binding to the CH1 region.</p>
<p id="__p32">The increased binding of p35srj to p300/CBP following HIF-1 activation may have important functional consequences. p35srj could interfere with the HIF-1α p300/CBP interaction, by blocking functional p300/CBP–CH1 sites, resulting in a degree of negative feedback, and fine-tuning HIF-1 transactivation. In support of this hypothesis, we found that p300–CH1 species that can successfully titrate endogenous p35srj enhanced endogenous HIF-1 function reproducibly. Also, consistent with this model, the timing of hypoxia induction of erythropoietin and heme-oxygenase mRNAs is characterized by an increase followed by a decrease, indicating that the response becomes attenuated with time (<a href="/pubmed/8381307" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734059">Fandrey and Bunn 1993</a>; <a href="/pubmed/9038135" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734046">Lee et al. 1997</a>). Against this hypothesis is the fact that most of cellular p300/CBP is apparently not bound to p35srj (see Fig. <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Fig.6B).</span></span><span>6</span></a>B). A number of other factors, e.g., STAT2 (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734038">Bhattacharya et al. 1996</a>), ets-1 (<a href="/pubmed/9528793" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734067">Yang et al. 1998</a>), NFκB-p65 (<a href="#B40" class="cite-reflink bibr popnode">Zhong et al. 1998</a>), p53, and MDM2 (<a href="#B10" class="cite-reflink bibr popnode">Grossman et al. 1998</a>) bind to p300/CBP–CH1, and could occupy available binding sites. A recent study has in fact shown that STAT2 and NFκB compete for p300/CBP at the CH1 binding site (<a href="/pubmed/9606194" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734050">Hottiger et al. 1998</a>). This indicates that functional p300/CBP–CH1 sites could be limited in vivo by occupying factors. Thus, in spite of there being a considerable excess of total p300/CBP over p35srj, variations in p35srj level could significantly affect the proportion of available functional CH1 sites in vivo, and thus modulate HIF-1 function. The transcriptional activation of a negative feedback regulator has been described in at least two other systems: NFκB and p53 transcriptionally activate the synthesis of their respective inhibitors, IκB-α and MDM2 (<a href="/pubmed/8262046" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734063">Le Bail et al. 1993</a>; for review, see <a href="/pubmed/8654922" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734085">Ko and Prives 1996</a>).</p>
<p id="__p33">Our data indicate that p35srj is constitutively bound to p300–CH1. In the context of the aforementioned model, this may serve as a safety mechanism, restricting inappropriate access of HIF-1α molecules that are in the basal state, to p300/CBP. This may be important in preventing illegitimate transcription at promoters containing HIF-1 sites. Because p35srj can also inhibit the binding and function of at least one other CH1-dependent transcription factor (STAT2), it is possible that it serves to regulate transcription factor access to this region of p300/CBP more generally.</p>
<p id="__p34">The specificity of the p35srj–CH1 interaction suggests that it may function to prevent titration of cellular p300/CBP by HIF-1. A number of studies have shown that transcription factors can compete for limiting amounts of p300/CBP, resulting in cross-talk between different signaling pathways (<a href="/pubmed/8616895" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734055">Kamei et al. 1996</a>; <a href="/pubmed/9215639" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734070">Avantaggiati et al. 1997</a>; <a href="/pubmed/9037008" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734052">Horvai et al. 1997</a>). Moreover, studies of the Rubinstein-Taybi syndrome (<a href="/pubmed/7630403" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734089">Petrij et al. 1995</a>), of heterozygous p300 and CBP knockout mice (<a href="/pubmed/9590171" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734076">Yao et al. 1998</a>), indicate that partial loss of p300 or CBP function results in an abnormal phenotype. This, again, shows that p300/CBP proteins are functionally limiting in the cell.</p>
<p id="__p35">Because p35srj does not affect the function of at least two, non-CH1 binding, p300-interacting transcription factors, it is conceivable that it reserves a subset of p300/CBP for use by these factors. Thus, p35srj may compartmentalize p300/CBP into certain discrete, functional subsets. This may be important for maintaining normal cellular function during hypoxia, possibly by limiting competition between HIF-1 and p300/CBP-dependent transcription factors binding at other sites than CH1 for use of the coactivation function of p300/CBP.</p>
<p id="__p36">P35srj may also function to link certain transcription factors to p300/CBP, as is the case for src-1, which participates in the interactions between certain nuclear hormone receptors and p300/CBP (<a href="/pubmed/8876171" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734041">Hanstein et al. 1996</a>; <a href="/pubmed/8855229" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734064">Yao et al. 1996</a>). In keeping with this idea, the carboxyl terminus of p35srj/MRG1 contains a strong transactivation domain (<a href="/pubmed/9434189" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734095">Shioda et al. 1997</a>), which can be inhibited by blocking p300/CBP function with adenoviral E1A (S. Bhattacharya and D.M. Livingston, unpubl.). Also supporting this idea is the observation that the related protein, MSG1, which contains a conserved, high-affinity p300/CBP-binding domain, has been shown recently to function as a coactivator for the transcription factor SMAD4 (<a href="/pubmed/9707553" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734037">Shioda et al. 1998</a>), and could presumably link SMAD4 to p300/CBP-CH1. Thus HIF-1 activation may result in the generation of a p35srj–p300/CBP coactivator complex that could have an important role in cellular function.</p>
<p id="__p37">In addition to a role in the HIF response, p35srj, and the related protein, MSG1, may have other, as yet unsuspected functions. Both p35srj and MSG1 likely play a significant role in development, as their mRNA levels are regulated during embryogenesis (<a href="/pubmed/9533950" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734087">Dunwoodie et al. 1998</a>). Gene-targeting experiments will serve to distinguish the functions of these developmentally regulated p300/CBP-binding proteins and will further test the models of p35srj function, proposed above.</p>
</div>
<div id="__sec11" class="sec">
<h2 class="head no_bottom_margin" id="__sec11title">Materials and methods</h2>
<div id="__sec12" class="sec sec-first">
<h3>Cloning</h3>
<p id="__p38">Expression cloning using GST–CH1 and a λgt11 HeLa cell library (Clontech) was performed as described previously (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734047">Bhattacharya et al. 1996</a>). Standard cloning procedures (<a href="#B3" class="cite-reflink bibr popnode">Ausubel et al. 1995</a>) were used to obtain a full-length p35srj clone from a λZAP HEK293 cell library (gift of Bill Kaelin, Dana-Farber Cancer Institute). The HeLa and the longest 293 clone were sequenced completely. A human EST clone encoding MSG1 was obtained (EST accession no. 270311 <a id="__tag_255092146" class="tag_hotlink" href="/nuccore/1165507"><span class="tag-json">{"type":"entrez-nucleotide","attrs":{"text":"N41476","term_id":"1165507"}}</span>N41476</a>, Research Genetics) and was sequenced. The sequence of murine p35srj was deduced from the murine p35srj genomic sequence (S. Bhattacharya and D.M. Livingston, unpubl.). The p35srj promoter was cloned by screening a human λEMBL3 SP6/T7 genomic library (Clontech) with a <sup>32</sup>P-labeled fragment of <em>p35srj</em> cDNA. Promoter fragments were subcloned into pBluescript (Stratagene) and sequenced.</p>
</div>
<div id="__sec13" class="sec">
<h3>Polyclonal and monoclonal antibodies</h3>
<p id="__p39">Anti-p35srj polyclonal and monoclonal antibodies (JA22) were raised by immunizing rabbits or mice with GST–p35srj (residues 66–270). JA22 is IgG1k, and its epitope maps between residues 66–124 of p35srj (S. Bhattacharya and D.M. Livingston, unpubl.). The antibodies do not cross-react with MSG1 (data not shown). Anti-p300/CBP antibodies (AC26, AC238, AC240, RW128, and RW105) have been described previously (<a href="/pubmed/8668161" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734073">Eckner et al. 1996</a>). PAB419 is a monoclonal antibody to SV40 Tag and was a gift of Ed Harlow (MGH Cancer Center, Boston, MA). Anti-MIG polyclonal was obtained from Cappel.</p>
</div>
<div id="__sec14" class="sec">
<h3>Plasmids</h3>
<p id="__p40">Plasmids were generated using recombinant techniques (<a href="#B3" class="cite-reflink bibr popnode">Ausubel et al. 1995</a>). All mammalian expression plasmids used the CMV promoter. p35srj expression plasmids were constructed in the vector pcDNA3 (Invitrogen), and had a HA tag fused at the amino terminus. GAL4 and VP16 fusions were made in plasmid vectors, PCMXGAL4N, and PCMXVPN (gifts from Ron Evans, Salk Institute, San Diego, CA). Mutations were generated using a site-directed mutagenesis kit (Bio-Rad). <em>p35srj</em> promoter–reporter plasmids were constructed in pGL3-Basic (Promega). The p35srj 3× HRE–luc reporter (−1202/−1159) and mutant reporter plasmids were constructed in pTK–luc (gift of Tso-Pang Yao, Dana-Farber Cancer Institue). p300–CH1 linker-scanning mutants were generated by site directed mutagenesis, replacing six consecutive amino acid residues of the p300 CH1 region with an NAAIRS peptide linker. The mutant versions of CH1 were expressed in mammalian cells using the vector pCDNA3. Details of constructions are available upon request. E2–p300 and HA–p300 were described previously (<a href="/pubmed/7523245" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734079">Eckner et al. 1994</a>; <a href="/pubmed/7870178" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734066">Arany et al. 1995</a>). The E2–luc plasmid was a gift from Steve Grossman. The VEGF–luc reporter was a gift from Mark Goldberg (<a href="/pubmed/8917528" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734092">Arany et al. 1996</a>). The GAL4–luc plasmid was a gift from Ron Evans. GAL4–SREBP2 (residues 1–330) was a gift from Jon Oliner and Robert Tjian (HHMI, Berkeley, CA). GAL4–src1 (residues 789–993) was a gift from Tso-Pang Yao. GAL4–STAT2 and GST–CH1 have been described previously (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734083">Bhattacharya et al. 1996</a>). The HIF-1α and ARNT plasmids used to generate in vitro translates were gifts from Steve McKnight and Oliver Hankinson, respectively.</p>
</div>
<div id="__sec15" class="sec">
<h3>Immunoprecipitation, GST fusion-binding, Northern blotting, Western blotting, and gel-shift<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">assays</h3>
<p id="__p41">All reagents were obtained from Sigma unless otherwise indicated. Northern blotting, Western blotting, and immunoprecipitations were performed using standard techniques (<a href="#B3" class="cite-reflink bibr popnode">Ausubel et al. 1995</a>) as described (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734044">Bhattacharya et al. 1996</a>). The Northern blot in Figure <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Figure6A</span></span><span>6</span></a>A was a gift from Mark Goldberg (Brigham and Women’s Hospital, Boston, MA). p35srj Northern blots were probed with an <em>Eco</em>RI–<em>Eco</em>NI fragment encoding the amino terminus of the full-length human protein. GST fusion proteins were generated using pGEX vectors from Pharmacia, and in vitro binding reactions were performed as described previously, in buffer Hyb-75<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">+<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">1% milk (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734058">Bhattacharya et al. 1996</a>). All immunoprecipitations were performed, unless otherwise stated, in buffer containing Tris at pH 8 50 m<span class="small-caps">m</span>, NaCl 150 m<span class="small-caps">m</span>, NP-40 0.5%, protease inhibitors (2 μg/ml leupeptin; 3.6 μg/ml aprotinin; 1 m<span class="small-caps">m</span> PMSF), and 0.5 m<span class="small-caps">m</span> DTT. Western blots for p35srj were transferred in 10 m<span class="small-caps">m</span> CAPS pH11/20% methanol buffer onto PVDF membranes (Immobilon), which were blocked in 5% milk in PBS at 37°C. Membranes were incubated with a 1:10 dilution of JA22 tissue culture supernatant in TBS-T (Tris-buffered saline 0.05% Tween 20, 1% BSA) overnight, washed with TBS, and probed with anti-mouse IgG–HRP conjugate (Amersham). For some immunoprecipitation–Western blot experiments, an anti-p35srj polyclonal antibody was used for Western blotting (1:1000 dilution) and probed using protein-A HRP (Amersham). p300/CBP were detected in Western blots using a cocktail of antibodies (AC238, AC26, RW128). GAL4 proteins were detected using mAb RK51 (Santa Cruz). Signals were detected by ECL (Amersham) following the instructions of the manufacturer. Gel-shift assays were performed as described (<a href="/pubmed/7836384" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734060">Wang and Semenza 1995</a>) using 2.5 μl of programmed reticulocyte lysate as a source of HIF-1α or ARNT in a 20-μl reaction.</p>
</div>
<div id="__sec16" class="sec">
<h3>Immunostaining</h3>
<p id="__p42">p35srj immunostaining was performed using a method described previously (<a href="/pubmed/7523245" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734065">Eckner et al. 1994</a>). JA22 tissue culture supernatent was routinely employed as a source of antibody at a 1:10 dilution. Alternatively, anti-HA polyclonal antibody (BabCO) in PBTB (PBS containing 0.1%Triton X-100, and 3% BSA) was used. Secondary antibodies were donkey anti-mouse IgG–FITC to detect the monoclonal antibody, and goat anti-rabbit rhodamine (both from Jackson Labs), to detect the rabbit polyclonal antibody. Nuclei were counterstained with Hoechst 33452 (2 μg/ml).</p>
</div>
<div id="__sec17" class="sec">
<h3>Pulse-chase experiments</h3>
<p id="__p43">Proliferating C2C12 cells (in 3-cm dishes) were washed twice using warm methionine-free medium and starved for 30 min in methionine-free medium containing 10% dialyzed bovine serum. They were pulsed with 1 mCi (15 μl)/ml of [<sup>35</sup>S]methionine for 10 min at 37°C, and washed three times with chase medium (20% FCS<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">+<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">3 mg/ml cold excess methionine). Chased cells were collected at the indicated time points, lysed in RIPA buffer, and immunoprecipitated with anti-p35srj polyclonal antibody. Immunoprecipitates were fractionated by SDS-PAGE, and p35srj was visualized by autoradiography and quantitated using a Betascope.</p>
</div>
<div id="__sec18" class="sec">
<h3>In vitro peptide and protein competition/binding<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">experiments</h3>
<p id="__p44">Baculoviruses were generated using pFastbacHTb (GIBCO BRL) following the recommendations of the manufacturer. Baculoviral proteins were obtained by infecting SF21 cells and then harvesting them in five-pellet volumes of immunoprecipitation buffer containing 180 m<span class="small-caps">m</span> NaCl. Cell lysates (protein content 3.5 mg/ml) were frozen after the addition of glycerol to 10%. SF21 lysates contained equal amounts of p35srj or p35srj mut (mutant) by Western blot (data not shown). All binding reactions were performed at 4°C. Competition experiments using baculovirally encoded proteins was performed using 20 μl of GST–CH1 or GST beads (50% by volume), and 100 μl of SF21 cell lysate in 300 μl of immunoprecipitation buffer. Beads were preincubated with SF21 lysate for 1 hr before adding in vitro-translated proteins (10 μl). Binding proceeded for a further 2 hr following which beads were washed three times in immunoprecipitation buffer, boiled in sample buffer, and fractionated by SDS-PAGE. The p35srj peptide (DEEVLMSLVIEMGLDRIKELPELWLGQNEFDF) and a control, irrelevant 25-mer peptide (ALTIQLIQNHFVDEYDPTIEDSYRK) were dissolved in DMSO, and used in the competition reactions as shown. For these experiments, GST–CH1 or GST, (1 μg of eluted protein), was preincubated with the indicated peptide (2–20 μg) for 5 hr in 300 μl Hyb-75<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">+<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">1% milk buffer. All reaction mixtures were constituted to contain equal amounts of the DMSO vehicle (final 1.76%), which did not interfere with binding. <sup>35</sup>S-labeled, in vitro translated proteins were then added and binding reactions were carried out overnight, following which the relevant proteins were precipitated with glutathione–Sepharose beads, and analyzed as above.</p>
</div>
<div id="__sec19" class="sec">
<h3>Cells</h3>
<p id="__p45">Hep3B cells (gift of Eric Huang, Brigham and Women’s Hospital), were cultivated in α-MEM (GIBCO BRL) containing 10% fetal bovine serum in a 5% CO<sub>2</sub>-containing atmosphere, and passaged every three days. They were grown to confluence before addition of deferoxamine to 100 μ<span class="small-caps">m</span>. U2OS cells (ATCC), and the Hep3B cells in Figure <a href="/pmc/articles/PMC316375/figure/F6/" class="fig-table-link fig figpopup"><span>​<span class="figpopup-sensitive-area">Figure6A,</span></span><span>6</span></a>A, were cultivated in DMEM<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">+<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">10% fetal clone (HYCLONE).</p>
</div>
<div id="__sec20" class="sec sec-last">
<h3>Transfections and luciferase assays</h3>
<p id="__p46">Hep3B cells were plated in 24-well plates at 2.5<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">×<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="">10<sup>4</sup> cells per well, and were transfected the following day using Fugene 6 (Boehringer). Transfection mixtures contained 1 μl Fugene 6 and up to 0.5 μg of total plasmid per well, as recommended by the manufacturer. DFO (100 μ<span class="small-caps">m</span>) was added the following day; cells were harvested 16 hr later; and luciferase and β-galactosidase activity (from a cotransfected <em>CMV–lacZ</em> reporter) analyzed as described previously (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734078">Bhattacharya et al. 1996</a>). Luciferase activity was corrected for <em>lacZ</em> activity to normalize for transfection efficiency, and the data was presented as relative luciferase units (RLU). Amounts of DNA used per transfection refer to the amounts added per well of a 24-well plate. For immunostaining, U2OS cells were transfected on coverslips using the calcium-phosphate method, as described previously (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734061">Bhattacharya et al. 1996</a>). For transfections U20S were plated as described previously (<a href="/pubmed/8848048" class="cite-reflink bibr popnode tag_hotlink tag_tooltip" id="__tag_118734075">Bhattacharya et al. 1996</a>).</p>
</div>
</div>
<div id="__ackid1592202" class="sec">
<h2 class="head no_bottom_margin" id="__ackid1592202title">Acknowledgments</h2>
<div class="sec">
<p id="__p54">We are indebted to N. Chandramouli (Novartis) for synthesizing the p35srj peptides and to Lidia Sambucetti and Dahlia Cohen for their help in obtaining these reagents and for their support and cooperation during the course of this work. We are very grateful to Frank Bunn and Mark Goldberg for discussions, and Bill Kaelin for the gift of the 293ZAP library. We also wish to thank Jim DeCaprio, Bill Sellers, Pang Yao, and Steve Grossman for their many helpful discussions, Jenny Gan for her expert help with generating monoclonal antibodies, Liz Oldread for superb technical assistance, and Richard Eckner for his help and advice during the initial part of this project and invaluable gifts of reagents. S.B. thanks Jane for her support. This work was funded by grants from the National Institutes of Health (NIH) to D.M.L., by an NIH Mentored Clinical Scientist Development Award and a Welkome Senior Fellowship Award to S.B., and by a grant from the Dana-Farber Cancer Institute/Novartis Drug Development Program to D.M.L.</p>
<p id="__p55">The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked ‘advertisement’ in accordance with 18 USC section 1734 solely to indicate this fact.</p>
</div>
</div>
<div id="__notesid1592226" class="sec">
<h2 class="head no_bottom_margin" id="__notesid1592226title">Note added in proof</h2>
<p id="__p56">The GenBank accession number for the human p35srj sequence is <a id="__tag_118734223" class="tag_hotlink" href="/nuccore/4193945"><span class="tag-json">{"type":"entrez-nucleotide","attrs":{"text":"AF109161","term_id":"4193945"}}</span>AF109161</a>.</p>
</div>
<div id="__fn-groupid1595253" class="sec">
<h2 class="head no_bottom_margin" id="__fn-groupid1595253title">Footnotes</h2>
<div class="half_rhythm small"><div class="fn sec" id="__fnid1595255"><p id="__p57">E-MAIL <span class="e_id1595262">David_Livingston/at/dfci.harvard.edu</span>; FAX (617) 632-4381.</p></div></div>
</div>
<div id="__ref-listid1592249" class="sec">
<h2 class="head no_bottom_margin" id="__ref-listid1592249title">References</h2>
<div class="ref-list-sec sec" id="reference-list"><ul class="first-line-outdent">
<li id="B1"><span class="citation" id="__citation1">Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. <span><span class="ref-journal">Nature. </span>1995;<span class="ref-vol">374</span>:81–84.</span>  <span class="nowrap">[<a href="/pubmed/7870178" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B2"><span class="citation" id="__citation2">Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM. An essential role for p300/CBP in the cellular response to hypoxia. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1996;<span class="ref-vol">93</span>:12969–12973.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC24030/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8917528" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B3"><span class="citation" id="__citation3">Ausubel F, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. <span class="ref-journal">Short protocols in molecular biology.</span> New York, NY: John Wiley &amp; Sons; 1995. </span></li>
<li id="B4"><span class="citation" id="__citation4">Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. <span><span class="ref-journal">Cell. </span>1997;<span class="ref-vol">89</span>:1175–1184.</span>  <span class="nowrap">[<a href="/pubmed/9215639" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B5"><span class="citation" id="__citation5">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D’Andrea A, Livingston DM. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">383</span>:344–347.</span>  <span class="nowrap">[<a href="/pubmed/8848048" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B6"><span class="citation" id="__citation6">Dunwoodie SL, Rodriguez TA, Beddington RSP. Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis. <span><span class="ref-journal">Mech Dev. </span>1998;<span class="ref-vol">72</span>:27–40.</span>  <span class="nowrap">[<a href="/pubmed/9533950" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B7"><span class="citation" id="__citation7">Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. <span><span class="ref-journal">Genes &amp; Dev. </span>1994;<span class="ref-vol">8</span>:869–884.</span>  <span class="nowrap">[<a href="/pubmed/7523245" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B8"><span class="citation" id="__citation8">Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA. Association of p300 and CBP with simian virus 40 large T antigen. <span><span class="ref-journal">Mol Cell Biol. </span>1996;<span class="ref-vol">16</span>:3454–3464.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC231340/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8668161" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B9"><span class="citation" id="__citation9">Fandrey J, Bunn HF. In vivo and in vitro regulation of erythropoietin mRNA: Measurement by competitive polymerase chain reaction. <span><span class="ref-journal">Blood. </span>1993;<span class="ref-vol">81</span>:617–623.</span>  <span class="nowrap">[<a href="/pubmed/8381307" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B10"><span class="citation" id="__citation10">Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. <span><span class="ref-journal">Mol Cell. </span>1998;<span class="ref-vol">2</span>:405–415.</span></span></li>
<li id="B11"><span class="citation" id="__citation11">Guillemin K, Krasnow MA. The hypoxic response: Huffing and HIFing. <span><span class="ref-journal">Cell. </span>1997;<span class="ref-vol">89</span>:9–12.</span>  <span class="nowrap">[<a href="/pubmed/9094708" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B12"><span class="citation" id="__citation12">Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M. p300 is a component of an estrogen receptor coactivator complex. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1996;<span class="ref-vol">93</span>:11540–11545.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC38093/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8876171" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B13"><span class="citation" id="__citation13">Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1997;<span class="ref-vol">94</span>:1074–1079.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC19746/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9037008" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B14"><span class="citation" id="__citation14">Hottiger MO, Felzien LK, Nabel GJ. Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. <span><span class="ref-journal">EMBO J. </span>1998;<span class="ref-vol">17</span>:3124–3134.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1170651/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9606194" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B15"><span class="citation" id="__citation15">Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1998;<span class="ref-vol">95</span>:7987–7992.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC20916/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9653127" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B16"><span class="citation" id="__citation16">Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. Cellular and developmental control of O<sub>2</sub> homeostasis by hypoxia-inducible factor 1 α <span><span class="ref-journal">Genes &amp; Dev. </span>1998;<span class="ref-vol">12</span>:149–162.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC316445/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9436976" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B17"><span class="citation" id="__citation17">Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL. Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension. <span><span class="ref-journal">J Biol Chem. </span>1997;<span class="ref-vol">272</span>:19253–19260.</span>  <span class="nowrap">[<a href="/pubmed/9235919" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B18"><span class="citation" id="__citation18">Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1997;<span class="ref-vol">94</span>:5667–5672.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC20836/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9159130" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B19"><span class="citation" id="__citation19">Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">85</span>:403–414.</span>  <span class="nowrap">[<a href="/pubmed/8616895" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B20"><span class="citation" id="__citation20">Ko LJ, Prives C. p53: Puzzle and paradigm. <span><span class="ref-journal">Genes &amp; Dev. </span>1996;<span class="ref-vol">10</span>:1054–1072.</span>  <span class="nowrap">[<a href="/pubmed/8654922" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B21"><span class="citation" id="__citation21">Le Bail O, Schmidt-Ullrich R, Israel A. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-κB: Positive regulation by members of the rel/NF-κB family. <span><span class="ref-journal">EMBO J. </span>1993;<span class="ref-vol">12</span>:5043–5049.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC413764/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8262046" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B22"><span class="citation" id="__citation22">Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. <span><span class="ref-journal">J Biol Chem. </span>1997;<span class="ref-vol">272</span>:5375–5381.</span>  <span class="nowrap">[<a href="/pubmed/9038135" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B23"><span class="citation" id="__citation23">Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. <span><span class="ref-journal">J Biol Chem. </span>1995;<span class="ref-vol">270</span>:13333–13340.</span>  <span class="nowrap">[<a href="/pubmed/7768934" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B24"><span class="citation" id="__citation24">Li H, Ko HP, Whitlock JP. Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1α <span><span class="ref-journal">J Biol Chem. </span>1996;<span class="ref-vol">271</span>:21262–21267.</span>  <span class="nowrap">[<a href="/pubmed/8702901" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B25"><span class="citation" id="__citation25">Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. <span><span class="ref-journal">Genes &amp; Dev. </span>1996;<span class="ref-vol">10</span>:2903–2911.</span>  <span class="nowrap">[<a href="/pubmed/8918891" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B26"><span class="citation" id="__citation26">Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, Ommen GB, Goodman RH, Peters DJM, Breuning MH. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. <span><span class="ref-journal">Nature. </span>1995;<span class="ref-vol">376</span>:348–351.</span>  <span class="nowrap">[<a href="/pubmed/7630403" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B27"><span class="citation" id="__citation27">Pugh CW. Oxygen and genes in health and disease [editorial] <span><span class="ref-journal">Quart J Med. </span>1997;<span class="ref-vol">90</span>:307–310.</span></span></li>
<li id="B28"><span class="citation" id="__citation28">Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WG., Jr Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. <span><span class="ref-journal">Genes &amp; Dev. </span>1998;<span class="ref-vol">12</span>:95–106.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC316399/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9420334" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B29"><span class="citation" id="__citation29">Semenza GL, Rue EA, Iyer NV, Pang MG, Kearns WG. Assignment of the hypoxia-inducible factor 1α gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. <span><span class="ref-journal">Genomics. </span>1996;<span class="ref-vol">34</span>:437–439.</span>  <span class="nowrap">[<a href="/pubmed/8786149" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B30"><span class="citation" id="__citation30">Shikama N, Lyon J, La Thangue NB. The p300/CBP family: Integrating signals with transcription factors and chromatin. <span><span class="ref-journal">Trends Cell Biol. </span>1997;<span class="ref-vol">7</span>:230–236.</span></span></li>
<li id="B31"><span class="citation" id="__citation31">Shioda T, Fenner MH, Isselbacher KJ. msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1996;<span class="ref-vol">93</span>:12298–12303.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC37985/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8901575" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B32"><span class="citation" id="__citation32">Shioda T, Fenner MH, Isselbacher KJ. MSG1 and its related protein MRG1 share a transcription activating domain. <span><span class="ref-journal">Gene. </span>1997;<span class="ref-vol">204</span>:235–241.</span>  <span class="nowrap">[<a href="/pubmed/9434189" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B33"><span class="citation" id="__citation33">Shioda T, Lechleider RJ, Dunwoodie SL, Li H, Yahata T, de Caestecker MP, Fenner MH, Roberts AB, Isselbacher KJ. Transcriptional activating activity of Smad4: Roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1998;<span class="ref-vol">95</span>:9785–9790.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC21414/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9707553" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B34"><span class="citation" id="__citation34">Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. <span><span class="ref-journal">J Biol Chem. </span>1995;<span class="ref-vol">270</span>:1230–1237.</span>  <span class="nowrap">[<a href="/pubmed/7836384" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B35"><span class="citation" id="__citation35">Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O<sub>2</sub> tension. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1995;<span class="ref-vol">92</span>:5510–5514.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC41725/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/7539918" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B36"><span class="citation" id="__citation36">Wilson TE, Padgett KA, Johnston M, Milbrandt J. A genetic method for defining DNA-binding domains: Application to the nuclear receptor NGFI-B. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1993;<span class="ref-vol">90</span>:9186–9190.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC47527/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8415675" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B37"><span class="citation" id="__citation37">Yang C, Shapiro LH, Rivera M, Kumar A, Brindle PK. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. <span><span class="ref-journal">Mol Cell Biol. </span>1998;<span class="ref-vol">18</span>:2218–2229.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC121466/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/9528793" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B38"><span class="citation" id="__citation38">Yao TP, Ku G, Zhou N, Scully R, Livingston DM. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1996;<span class="ref-vol">93</span>:10626–10631.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC38204/">PMC free article</a>]</span>  <span class="nowrap">[<a href="/pubmed/8855229" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B39"><span class="citation" id="__citation39">Yao T-P, Oh SP, Fuchs M, Zhou N-D, Ch’ng L-E, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. <span><span class="ref-journal">Cell. </span>1998;<span class="ref-vol">93</span>:361–372.</span>  <span class="nowrap">[<a href="/pubmed/9590171" target="pmc_ext">PubMed</a>]</span></span></li>
<li id="B40"><span class="citation" id="__citation40">Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. <span><span class="ref-journal">Mol Cell. </span>1998;<span class="ref-vol">1</span>:661–671.</span></span></li>
</ul></div>
</div>
</div>
<hr class="whole_rhythm no_bottom_margin">
<h6 class="courtesy-note no_margin small">Articles from <span class="acknowledgment-journal-title">Genes &amp; Development</span> are provided here courtesy of <strong>Cold Spring Harbor Laboratory Press</strong>
</h6>
</div>
            

          </div>
          
          <div class="col four_col last">
            <div class="format-menu">
              <h2>Formats:</h2>
              <ul>
<li><a href="/pmc/articles/PMC316375/?report=abstract">Abstract</a></li> | <li class="selected">Full Text</li> | <li><a href="/pmc/articles/PMC316375/pdf/x8.pdf">PDF (1.4M)</a></li>
</ul>
</div>

            <div class="portlet brieflink">
  <div class="portlet_head">
    <div class="portlet_title">
      <h3>Related citations in PubMed</h3>
    </div>
    <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.PMCVPubmedRelatedArticlesP.Shutter" href="#" class="portlet_shutter" title="Show/hide content" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.PMCVPubmedRelatedArticlesP.Shutter"></a>
  </div>
  <div class="portlet_content">
  <ul>
<li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pubmed/9822602">Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.</a>
      <span class="source">[EMBO J. 1998]</span>
      <div class="brieflinkpop offscreen_noflow">Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.<div class="brieflinkpopdesc">
<em class="author">Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, Poellinger L. </em><em class="cit">EMBO J. 1998 Nov 16; 17(22):6573-86. </em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pubmed/12133832">Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein.</a>
      <span class="source">[J Biol Chem. 2002]</span>
      <div class="brieflinkpop offscreen_noflow">Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein.<div class="brieflinkpopdesc">
<em class="author">Ruas JL, Poellinger L, Pereira T. </em><em class="cit">J Biol Chem. 2002 Oct 11; 277(41):38723-30. Epub 2002 Jul 19.</em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pubmed/11940656">Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.</a>
      <span class="source">[Mol Cell Biol. 2002]</span>
      <div class="brieflinkpop offscreen_noflow">Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.<div class="brieflinkpopdesc">
<em class="author">Sang N, Fang J, Srinivas V, Leshchinsky I, Caro J. </em><em class="cit">Mol Cell Biol. 2002 May; 22(9):2984-92. </em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pubmed/12778114">Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.</a>
      <span class="source">[Nat Struct Biol. 2003]</span>
      <div class="brieflinkpop offscreen_noflow">Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.<div class="brieflinkpopdesc">
<em class="author">Freedman SJ, Sun ZY, Kung AL, France DS, Wagner G, Eck MJ. </em><em class="cit">Nat Struct Biol. 2003 Jul; 10(7):504-12. </em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pubmed/14594809">Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.</a>
      <span class="source">[J Biol Chem. 2004]</span>
      <div class="brieflinkpop offscreen_noflow">Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.<div class="brieflinkpopdesc">
<em class="author">De Guzman RN, Martinez-Yamout MA, Dyson HJ, Wright PE. </em><em class="cit">J Biol Chem. 2004 Jan 23; 279(4):3042-9. Epub 2003 Oct 31.</em>
</div>
</div>
    </li>
  </ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=9887100&amp;log%24=relatedreviews&amp;logdbfrom=pmc">See reviews...</a>
  <a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=9887100&amp;log%24=relatedarticles&amp;logdbfrom=pmc">See all...</a>
</div>
</div>

            <div class="portlet brieflink">
  <div class="portlet_head">
    <div class="portlet_title">
      <h3>Cited by other articles in PMC</h3>
    </div>
    <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.PMCVCitedByPmcArticlesP.Shutter" href="#" class="portlet_shutter" title="Show/hide content" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.PMCVCitedByPmcArticlesP.Shutter"></a>
  </div>
  <div class="portlet_content">
  <ul>
<li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pmc/articles/PMC3365797/">Development and Function of the Human Fetal Adrenal Cortex: A Key Component in the Feto-Placental Unit</a>
      <span class="source">[Endocrine Reviews. 2011]</span>
      <div class="brieflinkpop offscreen_noflow">Development and Function of the Human Fetal Adrenal Cortex: A Key Component in the Feto-Placental Unit<div class="brieflinkpopdesc">
<em class="author">Ishimoto H, Jaffe RB. </em><em class="cit">Endocrine Reviews. 2011 Jun; 32(3)317-355</em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pmc/articles/PMC3365139/">Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes</a>
      <span class="source">[Molecular Vision. ]</span>
      <div class="brieflinkpop offscreen_noflow">Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes<div class="brieflinkpopdesc">
<em class="author">Huang TQ, Wang Y, Ebrahem Q, Chen Y, Cheng C, Doughman YQ, Watanabe M, Dunwoodie SL, Yang YC. </em><em class="cit">Molecular Vision. 181260-1270</em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pmc/articles/PMC3300025/">Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling</a>
      <span class="source">[Nucleic Acids Research. 2012]</span>
      <div class="brieflinkpop offscreen_noflow">Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling<div class="brieflinkpopdesc">
<em class="author">Wollenick K, Hu J, Kristiansen G, Schraml P, Rehrauer H, Berchner-Pfannschmidt U, Fandrey J, Wenger RH, Stiehl DP. </em><em class="cit">Nucleic Acids Research. 2012 Mar; 40(5)1928-1943</em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pmc/articles/PMC3225227/">NOVEL COMPLEX INTEGRATING MITOCHONDRIA AND THE MICROTUBULAR CYTOSKELETON WITH CHROMOSOME REMODELING AND TUMOR SUPPRESSOR RASSF1 DEDUCED BY IN SILICO HOMOLOGY ANALYSIS, INTERACTION CLONING IN YEAST, AND COLOCALIZATION IN CULTURED CELLS</a>
      <span class="source">[In vitro cellular &amp; developmental biology. ...]</span>
      <div class="brieflinkpop offscreen_noflow">NOVEL COMPLEX INTEGRATING MITOCHONDRIA AND THE MICROTUBULAR CYTOSKELETON WITH CHROMOSOME REMODELING AND TUMOR SUPPRESSOR RASSF1 DEDUCED BY IN SILICO HOMOLOGY ANALYSIS, INTERACTION CLONING IN YEAST, AND COLOCALIZATION IN CULTURED CELLS<div class="brieflinkpopdesc">
<em class="author">LIU L, VO A, LIU G, MCKEEHAN WL. </em><em class="cit">In vitro cellular &amp; developmental biology. Animal. 2002; 38(10)582-594</em>
</div>
</div>
    </li>
    <li class="brieflinkpopper two_line">
      <a class="brieflinkpopperctrl" href="/pmc/articles/PMC3179481/">Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis</a>
      <span class="source">[PLoS ONE. ]</span>
      <div class="brieflinkpop offscreen_noflow">Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis<div class="brieflinkpopdesc">
<em class="author">Di Palma T, Conti A, de Cristofaro T, Scala S, Nitsch L, Zannini M. </em><em class="cit">PLoS ONE. 6(9)e25162</em>
</div>
</div>
    </li>
  </ul>
<a class="seemore" href="citedby/">See all...</a>
</div>
</div>

            <div class="portlet brieflink">
  <div class="portlet_head">
    <div class="portlet_title">
      <h3>Links</h3>
    </div>
    <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.PMCVDiscoveryDbLinksP.Shutter" href="#" class="portlet_shutter" title="Show/hide content" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.PMCVDiscoveryDbLinksP.Shutter"></a>
  </div>
  <div class="portlet_content DiscoveryDbLinks">
  <ul>
<li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=nucest&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_nucest&amp;IdsFromResult=316375">EST</a>
      <div class="brieflinkpop offscreen_noflow">EST<div class="brieflinkpopdesc">Published EST sequences</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=316375">Gene</a>
      <div class="brieflinkpop offscreen_noflow">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=316375">GEO Profiles</a>
      <div class="brieflinkpop offscreen_noflow">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=homologene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_homologene&amp;IdsFromResult=316375">HomoloGene</a>
      <div class="brieflinkpop offscreen_noflow">HomoloGene<div class="brieflinkpopdesc">HomoloGene links</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=nuccore&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_nuccore&amp;IdsFromResult=316375">Nucleotide</a>
      <div class="brieflinkpop offscreen_noflow">Nucleotide<div class="brieflinkpopdesc">Published Nucleotide sequences</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=omim&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_omim&amp;IdsFromResult=316375">OMIM</a>
      <div class="brieflinkpop offscreen_noflow">OMIM<div class="brieflinkpopdesc">OMIM record citing PubMed</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=protein&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_protein&amp;IdsFromResult=316375">Protein</a>
      <div class="brieflinkpop offscreen_noflow">Protein<div class="brieflinkpopdesc">Published protein sequences</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pubmed/9887100/">PubMed</a>
      <div class="brieflinkpop offscreen_noflow">PubMed<div class="brieflinkpopdesc">PubMed citation for this article</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=316375">Taxonomy</a>
      <div class="brieflinkpop offscreen_noflow">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
    </li>
    <li class="brieflinkpopper">
      <a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;cmd=Link&amp;LinkName=pmc_taxonomy&amp;doptcmdl=TxTree&amp;IdsFromResult=316375">Taxonomy Tree</a>
      <div class="brieflinkpop offscreen_noflow">Taxonomy Tree</div>
    </li>
  </ul>
</div>
</div>

            <div class="portlet">
  <div class="portlet_head">
    <div class="portlet_title">
      <h3>Recent activity</h3>
    </div>
    <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.Shutter" href="#" class="portlet_shutter" title="Show/hide content" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.Shutter"></a>
  </div>
  <div class="portlet_content">
    <div id="HTDisplay" class="">
      <div class="action">
        <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.ClearHistory" href="?cmd=ClearHT&amp;" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.ClearHistory">
                                Clear
                            </a>
        <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.HistoryToggle" class="HTOn" href="?cmd=HTOff&amp;" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.HistoryToggle">
                                Turn Off                        
                            </a>
        <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.HistoryToggle" class="HTOff" href="?cmd=HTOn&amp;" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.HistoryToggle">
                                Turn On                        
                            </a>
      </div>
      <ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
          <a class="htb ralinkpopperctrl" href="/portal/utils/pageresolver.fcgi?recordid=1343087763603624">Functional role of p35srj, a novel p300/CBP binding protein, during transactivat...</a>
          <div class="ralinkpop offscreen_noflow">Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1<div class="brieflinkpopdesc">Genes &amp; Development. 1999 Jan 1; 13(1)64-75</div>
</div>
          <div class="tertiary">PMC</div>
        </li>
      </ul>
<p class="HTOn">Your browsing activity is empty.</p>
      <p class="HTOff">Activity recording is turned off.</p>
      <p id="turnOn" class="HTOff">
        <a name="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.HistoryOn" href="?cmd=HTOn&amp;" id="PMCVAppLayout.AppController.Page.PMCVArticlePageC.HistoryDisplay.HistoryOn">Turn recording back on</a>
      </p>
      <a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
    </div>
  </div>
</div>


            
            <div class="portlet brieflink pmc_para_cit" id="crb-316375-__p4" name="crb-316375-__p4">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/7539918/">Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1995]</span>
        <div class="alt-note">
          <div class="authors">Wang GL, Jiang BH, Rue EA, Semenza GL</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1995 Jun 6; 92(12):5510-4.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9094708/"><span class="invert">Review</span> The hypoxic response: huffing and HIFing.</a>
        <span class="one_line_source">[Cell. 1997]</span>
        <div class="alt-note">
          <div class="authors">Guillemin K, Krasnow MA</div>
          <div class="citation">Cell. 1997 Apr 4; 89(1):9-12.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8702901/">Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha.</a>
        <span class="one_line_source">[J Biol Chem. 1996]</span>
        <div class="alt-note">
          <div class="authors">Li H, Ko HP, Whitlock JP</div>
          <div class="citation">J Biol Chem. 1996 Aug 30; 271(35):21262-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9235919/">Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.</a>
        <span class="one_line_source">[J Biol Chem. 1997]</span>
        <div class="alt-note">
          <div class="authors">Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL</div>
          <div class="citation">J Biol Chem. 1997 Aug 1; 272(31):19253-60.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9159130/">Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1997]</span>
        <div class="alt-note">
          <div class="authors">Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5667-72.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9653127/">Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1998]</span>
        <div class="alt-note">
          <div class="authors">Huang LE, Gu J, Schau M, Bunn HF</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14):7987-92.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9436976/">Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.</a>
        <span class="one_line_source">[Genes Dev. 1998]</span>
        <div class="alt-note">
          <div class="authors">Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL</div>
          <div class="citation">Genes Dev. 1998 Jan 15; 12(2):149-62.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p5" name="crb-316375-__p5">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8917528/">An essential role for p300/CBP in the cellular response to hypoxia.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):12969-73.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p6" name="crb-316375-__p6">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8917528/">An essential role for p300/CBP in the cellular response to hypoxia.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):12969-73.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9528793/">A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions.</a>
        <span class="one_line_source">[Mol Cell Biol. 1998]</span>
        <div class="alt-note">
          <div class="authors">Yang C, Shapiro LH, Rivera M, Kumar A, Brindle PK</div>
          <div class="citation">Mol Cell Biol. 1998 Apr; 18(4):2218-29.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8901575/">msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Shioda T, Fenner MH, Isselbacher KJ</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12298-303.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p7" name="crb-316375-__p7">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p8" name="crb-316375-__p8">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8901575/">msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Shioda T, Fenner MH, Isselbacher KJ</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12298-303.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p9" name="crb-316375-__p9">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/7523245/">Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.</a>
        <span class="one_line_source">[Genes Dev. 1994]</span>
        <div class="alt-note">
          <div class="authors">Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM</div>
          <div class="citation">Genes Dev. 1994 Apr 15; 8(8):869-84.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p15" name="crb-316375-__p15">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/9653127/">Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1998]</span>
        <div class="alt-note">
          <div class="authors">Huang LE, Gu J, Schau M, Bunn HF</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14):7987-92.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8702901/">Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha.</a>
        <span class="one_line_source">[J Biol Chem. 1996]</span>
        <div class="alt-note">
          <div class="authors">Li H, Ko HP, Whitlock JP</div>
          <div class="citation">J Biol Chem. 1996 Aug 30; 271(35):21262-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9235919/">Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.</a>
        <span class="one_line_source">[J Biol Chem. 1997]</span>
        <div class="alt-note">
          <div class="authors">Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL</div>
          <div class="citation">J Biol Chem. 1997 Aug 1; 272(31):19253-60.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9159130/">Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1997]</span>
        <div class="alt-note">
          <div class="authors">Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5667-72.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p18" name="crb-316375-__p18">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8702901/">Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha.</a>
        <span class="one_line_source">[J Biol Chem. 1996]</span>
        <div class="alt-note">
          <div class="authors">Li H, Ko HP, Whitlock JP</div>
          <div class="citation">J Biol Chem. 1996 Aug 30; 271(35):21262-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9235919/">Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.</a>
        <span class="one_line_source">[J Biol Chem. 1997]</span>
        <div class="alt-note">
          <div class="authors">Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL</div>
          <div class="citation">J Biol Chem. 1997 Aug 1; 272(31):19253-60.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p20" name="crb-316375-__p20">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/7768934/">Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.</a>
        <span class="one_line_source">[J Biol Chem. 1995]</span>
        <div class="alt-note">
          <div class="authors">Levy AP, Levy NS, Wegner S, Goldberg MA</div>
          <div class="citation">J Biol Chem. 1995 Jun 2; 270(22):13333-40.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p21" name="crb-316375-__p21">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8918891/">SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.</a>
        <span class="one_line_source">[Genes Dev. 1996]</span>
        <div class="alt-note">
          <div class="authors">Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R</div>
          <div class="citation">Genes Dev. 1996 Nov 15; 10(22):2903-11.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8855229/">The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Yao TP, Ku G, Zhou N, Scully R, Livingston DM</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Oct 1; 93(20):10626-31.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p23" name="crb-316375-__p23">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8786149/">Assignment of the hypoxia-inducible factor 1alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q.</a>
        <span class="one_line_source">[Genomics. 1996]</span>
        <div class="alt-note">
          <div class="authors">Semenza GL, Rue EA, Iyer NV, Pang MG, Kearns WG</div>
          <div class="citation">Genomics. 1996 Jun 15; 34(3):437-9.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p24" name="crb-316375-__p24">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/7836384/">Purification and characterization of hypoxia-inducible factor 1.</a>
        <span class="one_line_source">[J Biol Chem. 1995]</span>
        <div class="alt-note">
          <div class="authors">Wang GL, Semenza GL</div>
          <div class="citation">J Biol Chem. 1995 Jan 20; 270(3):1230-7.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p26" name="crb-316375-__p26">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8415675/">A genetic method for defining DNA-binding domains: application to the nuclear receptor NGFI-B.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1993]</span>
        <div class="alt-note">
          <div class="authors">Wilson TE, Padgett KA, Johnston M, Milbrandt J</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1993 Oct 1; 90(19):9186-90.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9420334/">Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.</a>
        <span class="one_line_source">[Genes Dev. 1998]</span>
        <div class="alt-note">
          <div class="authors">Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WG Jr</div>
          <div class="citation">Genes Dev. 1998 Jan 1; 12(1):95-106.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p32" name="crb-316375-__p32">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8381307/">In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction.</a>
        <span class="one_line_source">[Blood. 1993]</span>
        <div class="alt-note">
          <div class="authors">Fandrey J, Bunn HF</div>
          <div class="citation">Blood. 1993 Feb 1; 81(3):617-23.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9038135/">Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia.</a>
        <span class="one_line_source">[J Biol Chem. 1997]</span>
        <div class="alt-note">
          <div class="authors">Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM</div>
          <div class="citation">J Biol Chem. 1997 Feb 28; 272(9):5375-81.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9528793/">A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions.</a>
        <span class="one_line_source">[Mol Cell Biol. 1998]</span>
        <div class="alt-note">
          <div class="authors">Yang C, Shapiro LH, Rivera M, Kumar A, Brindle PK</div>
          <div class="citation">Mol Cell Biol. 1998 Apr; 18(4):2218-29.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9606194/">Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.</a>
        <span class="one_line_source">[EMBO J. 1998]</span>
        <div class="alt-note">
          <div class="authors">Hottiger MO, Felzien LK, Nabel GJ</div>
          <div class="citation">EMBO J. 1998 Jun 1; 17(11):3124-34.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8262046/">Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family.</a>
        <span class="one_line_source">[EMBO J. 1993]</span>
        <div class="alt-note">
          <div class="authors">Le Bail O, Schmidt-Ullrich R, Israël A</div>
          <div class="citation">EMBO J. 1993 Dec 15; 12(13):5043-9.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8654922/"><span class="invert">Review</span> p53: puzzle and paradigm.</a>
        <span class="one_line_source">[Genes Dev. 1996]</span>
        <div class="alt-note">
          <div class="authors">Ko LJ, Prives C</div>
          <div class="citation">Genes Dev. 1996 May 1; 10(9):1054-72.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p34" name="crb-316375-__p34">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8616895/">A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.</a>
        <span class="one_line_source">[Cell. 1996]</span>
        <div class="alt-note">
          <div class="authors">Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG</div>
          <div class="citation">Cell. 1996 May 3; 85(3):403-14.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9215639/">Recruitment of p300/CBP in p53-dependent signal pathways.</a>
        <span class="one_line_source">[Cell. 1997]</span>
        <div class="alt-note">
          <div class="authors">Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K</div>
          <div class="citation">Cell. 1997 Jun 27; 89(7):1175-84.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9037008/">Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1997]</span>
        <div class="alt-note">
          <div class="authors">Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1997 Feb 18; 94(4):1074-9.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/7630403/">Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.</a>
        <span class="one_line_source">[Nature. 1995]</span>
        <div class="alt-note">
          <div class="authors">Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ</div>
          <div class="citation">Nature. 1995 Jul 27; 376(6538):348-51.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9590171/">Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.</a>
        <span class="one_line_source">[Cell. 1998]</span>
        <div class="alt-note">
          <div class="authors">Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R</div>
          <div class="citation">Cell. 1998 May 1; 93(3):361-72.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p36" name="crb-316375-__p36">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8876171/">p300 is a component of an estrogen receptor coactivator complex.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11540-5.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8855229/">The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Yao TP, Ku G, Zhou N, Scully R, Livingston DM</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Oct 1; 93(20):10626-31.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9434189/">MSG1 and its related protein MRG1 share a transcription activating domain.</a>
        <span class="one_line_source">[Gene. 1997]</span>
        <div class="alt-note">
          <div class="authors">Shioda T, Fenner MH, Isselbacher KJ</div>
          <div class="citation">Gene. 1997 Dec 19; 204(1-2):235-41.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/9707553/">Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1998]</span>
        <div class="alt-note">
          <div class="authors">Shioda T, Lechleider RJ, Dunwoodie SL, Li H, Yahata T, de Caestecker MP, Fenner MH, Roberts AB, Isselbacher KJ</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1998 Aug 18; 95(17):9785-90.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p37" name="crb-316375-__p37">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/9533950/">Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis.</a>
        <span class="one_line_source">[Mech Dev. 1998]</span>
        <div class="alt-note">
          <div class="authors">Dunwoodie SL, Rodriguez TA, Beddington RS</div>
          <div class="citation">Mech Dev. 1998 Mar; 72(1-2):27-40.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p38" name="crb-316375-__p38">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p39" name="crb-316375-__p39">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8668161/">Association of p300 and CBP with simian virus 40 large T antigen.</a>
        <span class="one_line_source">[Mol Cell Biol. 1996]</span>
        <div class="alt-note">
          <div class="authors">Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA</div>
          <div class="citation">Mol Cell Biol. 1996 Jul; 16(7):3454-64.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p40" name="crb-316375-__p40">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/7523245/">Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.</a>
        <span class="one_line_source">[Genes Dev. 1994]</span>
        <div class="alt-note">
          <div class="authors">Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM</div>
          <div class="citation">Genes Dev. 1994 Apr 15; 8(8):869-84.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/7870178/">A family of transcriptional adaptor proteins targeted by the E1A oncoprotein.</a>
        <span class="one_line_source">[Nature. 1995]</span>
        <div class="alt-note">
          <div class="authors">Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R</div>
          <div class="citation">Nature. 1995 Mar 2; 374(6517):81-4.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8917528/">An essential role for p300/CBP in the cellular response to hypoxia.</a>
        <span class="one_line_source">[Proc Natl Acad Sci U S A. 1996]</span>
        <div class="alt-note">
          <div class="authors">Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM</div>
          <div class="citation">Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):12969-73.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p41" name="crb-316375-__p41">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
      <li class="expanded">
        <a href="/pubmed/7836384/">Purification and characterization of hypoxia-inducible factor 1.</a>
        <span class="one_line_source">[J Biol Chem. 1995]</span>
        <div class="alt-note">
          <div class="authors">Wang GL, Semenza GL</div>
          <div class="citation">J Biol Chem. 1995 Jan 20; 270(3):1230-7.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p42" name="crb-316375-__p42">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/7523245/">Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.</a>
        <span class="one_line_source">[Genes Dev. 1994]</span>
        <div class="alt-note">
          <div class="authors">Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM</div>
          <div class="citation">Genes Dev. 1994 Apr 15; 8(8):869-84.</div>
        </div>
      </li>
    </ul>
</div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb-316375-__p46" name="crb-316375-__p46">
  <div class="portlet_head"></div>
  <div class="portlet_content">
    <ul>
<li class="expanded">
        <a href="/pubmed/8848048/">Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.</a>
        <span class="one_line_source">[Nature. 1996]</span>
        <div class="alt-note">
          <div class="authors">Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM</div>
          <div class="citation">Nature. 1996 Sep 26; 383(6598):344-7.</div>
        </div>
      </li>
    </ul>
</div>
</div>

          </div>
        </div>
          
        
        

        <div>
    
    <div id="NCBIFooter_dynamic">
            <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; PubMed Central (PMC)</span>
</div>
    <a id="help-desk-link" class="help_desk" target="_blank" href="/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=article&amp;Snapshot=/projects/PMC/PMCViewer@2.6&amp;Time=2012-07-23T19:56:03-04:00&amp;Host=ptpmc201">Write to the Help
            Desk</a>
    <noscript><img alt="" src="/stat?jsdisabled=true&amp;ncbi_app=pmc&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_phid=F4FB6D7900DE4701000000000024E232"></noscript>

    </div>

    <div>
        <div class="footer" id="footer">
    
    <div class="subfooter">
        <h2 class="offscreen_noflow">Simple NCBI Directory</h2>
        <ul class="foot_list" id="getting_started">
<li><h3>Getting Started</h3></li>
            
            <li><a href="/Education/">NCBI Education</a></li>
            <li><a href="/books/NBK3831/">NCBI Help Manual</a></li>
            <li><a href="/books/NBK21101/">NCBI Handbook</a></li>
            <li><a href="/guide/training-tutorials/">Training &amp; Tutorials</a></li>
        </ul>
<ul class="foot_list" id="resources">
<li><h3>Resources</h3></li>
            
        <li><a href="/guide/chemicals-bioassays">Chemicals &amp; Bioassays</a></li>
<li><a href="/guide/data-software">Data &amp; Software</a></li>
<li><a href="/guide/dna-rna">DNA &amp; RNA</a></li>
<li><a href="/guide/domains-structures">Domains &amp; Structures</a></li>
<li><a href="/guide/genes-expression">Genes &amp; Expression</a></li>
<li><a href="/guide/genetics-medicine">Genetics &amp; Medicine</a></li>
<li><a href="/guide/genomes-maps">Genomes &amp; Maps</a></li>
<li><a href="/guide/homology">Homology</a></li>
<li><a href="/guide/literature">Literature</a></li>
<li><a href="/guide/proteins">Proteins</a></li>
<li><a href="/guide/sequence-analysis">Sequence Analysis</a></li>
<li><a href="/guide/taxonomy">Taxonomy</a></li>
<li><a href="/guide/training-tutorials">Training &amp; Tutorials</a></li>
<li><a href="/guide/variation">Variation</a></li>
</ul>
<ul class="foot_list" id="popular">
<li><h3>Popular</h3></li>
            <li><a href="/pubmed/">PubMed</a></li>
            <li><a href="/nucleotide/">Nucleotide</a></li>
            <li><a href="http://blast.ncbi.nlm.nih.gov/">BLAST</a></li>
            <li><a href="http://www.pubmedcentral.nih.gov/" class="newdomain">PubMed Central</a></li>
            <li><a href="/gene/">Gene</a></li>
            <li><a href="/books/">Bookshelf</a></li>
            <li><a href="/protein/">Protein</a></li>
            <li><a href="/omim/">OMIM</a></li>
            <li><a href="/genome/">Genome</a></li>
            <li><a href="/snp/">SNP</a></li>
            <li><a href="/Structure/">Structure</a></li>
        </ul>
<ul class="foot_list" id="featured">
<li><h3>Featured</h3></li>
            <li><a href="/gtr/">Genetic Testing Registry</a></li>
            <li><a href="/pubmedhealth/">PubMed Health</a></li>
            <li><a href="/Genbank/">GenBank</a></li>
            <li><a href="/refseq/">Reference Sequences</a></li>
            <li><a href="/mapview/">Map Viewer</a></li>
            <li><a href="/genome/guide/human/">Human Genome</a></li>
            <li><a href="/genome/guide/mouse/">Mouse Genome</a></li>
            <li><a href="/genomes/FLU/">Influenza Virus</a></li>
            <li><a href="/tools/primer-blast/">Primer-BLAST</a></li>
            <li><a href="/Traces/sra/">Sequence Read Archive</a></li>
        </ul>
<ul class="foot_list" id="info">
<li><h3>NCBI Information</h3></li>
            <li><a href="/About/">About NCBI</a></li>
            <li><a href="/research/">Research at NCBI</a></li>
            <li><a href="/books/NBK1969/">NCBI Newsletter</a></li>
            <li><a href="/Ftp/">NCBI FTP Site</a></li>
            <li><a class="external" href="http://www.facebook.com/ncbi.nlm">NCBI on Facebook</a></li>
            <li><a class="external" href="http://www.twitter.com/ncbi">NCBI on Twitter</a></li>
            <li><a class="external" href="http://www.youtube.com/ncbinlm">NCBI on YouTube</a></li>
        </ul>
</div>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="/About/disclaimer.html">Copyright</a> | <a href="/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | <a href="/About/accessibility.html">Accessibility</a> | <a href="/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    </div>
    </div>
</div>

        
      </div>
    </div>

    
    <div id="body-link-poppers"></div>
    
    <span class="PAFAppResources"></span>

    
    
    
    
    <span class="pagefixtures"></span>



  
</body>
</html>
